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Man’s existence on this earth has been made possible only because 
of the vital role played by the plant kingdom in sustaining his life. Without 
the variety of living organism that makes up the world of plants, animal life 
would not survive and our planet would have been a barren and life less 
world of deserts1.
Plants are the only economic source of a number of well established 
and  important  drugs.  In  addition  they are  the  source  of  some chemical 
intermediates needed for the production of a number of drugs2.
Medicinal plants global view
The universal role of plants in the treatment of disease is exemplified 
by their employment in all the major systems of medicine. There is a great 
wealth  of  knowledge  concerning  the  medicinal,  narcotic  and  other 
properties of plants that is still transmitted from generation to generation to 
tribal societies. The knowledge of tribal (folk) medicines are enormous but 
has been lying dormant due to various reasons and is worthy exploration3.
By studying the folk medicine not only the Materia Medica of different 
systems will be enriched, but the economic status of the country will also 
become sound. As the medicinal plants are considered the natural wealth of 
the country, for internal consumption as well as for earning valuable foreign 
exchange4.
WHO views on Medicinal Plants
The world health organization has estimated that nearly 80% of the 
population of the developing countries meet their primary health care needs 
through  plant  based  traditional  medicine.  Towards  the  end  of  the  20 th 
century there began a revival of interest in traditional medicine not only in 
developing countries,  but also in the developed countries.  The revival  of 
interest in herbal drugs started mainly because of the widespread belief that 
green medicine is  healthier  than synthetic  products.  Now the increasing 
popularity of plant – based drugs are felt all over the world leading to fast 
growing market for herbal drugs, pharmaceuticals, nutraceuticals, functional 
foods and even cosmetics5.
Status of India
India has an ancient heritage of traditional medicine, perhaps largest 
producer  of  medicinal  herbs  and  is  rightly  called  “THE  BOTANICAL 
GARDEN  OF  THE  WORLD”. Medicinal  herbs  have  been  in  use  for 
thousand of years, in one form to another under the indigenous system of 
medicine6.
India was one of the pioneers in the development and practice of well 
documented  indigenous  systems  of  medicine,  particularly  Ayurvedha, 
Siddha  and  Unani.  The  Indian  population  has  depend  on  mostly  plant 
based crude drugs for the treatment of various ailments. Medicinal plants 
sector has traditionally occupied an important position in the socio-cultural, 
spiritual and medicine arena of rural and tribal lives of Tamil Nadu.
Contribution by Tamil Nadu
Siddha system is one of the ancient traditional systems of medicine in 
India. Siddhars, the spiritual scientists of Tamil Nadu are the founders of the 
scientific system. The basic concept of siddha of medicine is 
“Food is medicine; Medicine is food”. 
Saint Thiruvalluvar says,
“Miginum kuraiyinum noiseyyum noolar
Vali mudhala enniya moondru”.
“Wind, bile, phlegm three causes diseases
So doctors deem it more or less”
And regarding diagnosis,
“Noi naadi noimudhal naadi athuthanikum
Vaai naadi vayppa seyal”
“Test disease, it’s causes and cure
And apply remedy that is sure”7.
Modern Medicine – Demerits
Inspite  of  tremendous  advances  made  in  the  modern  system  of 
medicine  there  are  still  a  large  number  of  conditions  for  which  suitable 
drugs are not available in the modern system of medicine and thus,  we 
should denote, time, efforts, and found in those areas where new drugs are 
urgently  needed  and  such  areas  include  tropical  diseases,  rheumatic 
diseases,  viral  infection,  liver  disease,  bronchial  asthma,  diabetes, 
immunomodulators as adjuvant for chemotherapy and adaptogens8.
Natural products for modern medicine
Plants  have  been  used  for  medicine  from  the  time  immemorial 
because  they  have  fitted  the  immediate  personal  need,  are  easily 
accessible and inexpensive. Researchers have no doubt that nature is still 
the preeminent synthetic  chemist and that in plants particularly, there are 
almost infinite reserves of fascinating chemical constituents with actual and 
potential effects on the human body.
Plant products can also be useful as starting material for the semi 
synthetic preparation of other drugs. The main examples are plant steroids 
hormones.  Natural  products  continue  to  form  a  significant  proportion  of 
drugs in current use and of those under investigation. It has been estimated 
that  56%  of  the  lead  compounds  for  medicinal  in  the  British  National 
Formulary are natural products or are derived from natural products.
Natural products will continue to be important in three areas of drug 
discovery.
1. As targets for production by biotechnology.
2. As a source of new lead compounds of novel chemical structure.
3. As the active ingredients of useful treatments derived from traditional 
systems of medicine9.
Priorities in Medicinal plant research
The plant kingdom represents as enormous reservoir of biologically 
active molecules and so far only a small fraction of plants with medicinal 
activity has been assayed. Nearly 50% drugs used in medicine are of plant 
origin.
There  is  therefore  much  current  research  devoted  to  the 
phytochemical  investigation  of  higher  plants  which  have  ethnobotanical 
information associated with them.
The phytochemical  isolated are then screened for  different  type of 
biological activity.
The crude plants extracts can be first assayed for particular activities 
and the active fraction then assayed phytochemically10.
Phytonutrients – The Natural Drugs of the Future
Degenerative Diseases
Many advances in the diagnosing of diseases and the discovery of a 
myriad  of  new names to  diseases  has  occurred,  the  battle  to  increase 
quality  of  life  and  the  overcoming,  curing  and  proper  treatment  of 
degenerative diseases has been all but lost.  Allopathic medicine has not 
changed its treatment of cancer in over 40 years.  Though new drugs keep 
popping up, the results are still the same and the most effective treatment 
for  cancer  is  still  surgery.   Heart  disease,  diabetes,  arthritis,  leukemia, 
Alzheimer’s, Parkinson’s, Hodgkin’s and dozens of other disease names 
strike fear  into  our  minds and as we  age,  many of  us  contemplate...  ”. 
Which one will take me from this life and how will I fight it?” Today with the 
current standard of allopathic medicine it is only a matter of time before you 
are  beaten  by  one  of  the  many  known  or  even  unknown  degenerative 
diseases.   There  are  no  known  cures  to  any  of  these  degenerative 
diseases.
Currently your only option is a long list of prescription drugs that may 
alleviate symptoms but slowly eat away your body’s immunity and quality of 
life.
There is hope however.  For more than 20 years now scientists have 
been researching plants and discoveries made within the last 15 years may 
hold  some  of  the  answers  to  combating  many  of  the  degenerative 
diseases11,12.
Alzheimer’s disease
Alzheimer’s disease (AD),  also called Alzheimer disease or simply 
Alzheimer’s,  is  the  most  common  type  of  dementia.  Alzheimer’s  is  a 
degenerative and terminal disease for which there is no known cure. In its 
most common form, it afflicts individuals over 65 years old, although a less 
prevalent  early  onset  form  also  exists.  It  is  estimated  that  26.6  million 
people worldwide were afflicted by AD in 2006, which could quadruple by 
2050, although estimate very greatly.  The disease was first described by 
Alois Alzheimer.
Symptoms of AD
In  the  early  stages,  the  most  commonly  recognized  symptom  is 
memory loss,  such as the difficulty  to  remember  recently  learned facts. 
Earlier occurring symptoms are often mistaken as being noncritical age – 
related complaints, or forms of stress. As the disease advances symptoms 
include confusion, anger, mood swings, language breakdown, long – term 
memory  loss,  and  the  general  withdrawal  of  the  sufferer  as  his  or  her 
senses  decline.  Gradually,  minor  and  major  bodily  functions  are  lost, 
leading ultimately to death.
The  cause  and  progression  of  Alzheimer’s  disease  are  not  well 
understood.
Characteristics of AD
The disease course is divided into four  stages,  with a progressive 






Three major competing hypothesis exist to explain the cause of the 
disease are 
1. Cholinergic hypothesis (Selective neuronal loss)
2. Amyloid hypothesis (Senile plaques)
3. Tau protein hypothesis (Neurofibrillary tangles)
Current Treatment
Four  medications,  to  treat  the cognitive  manifestations  of  AD,  are 
currently  approved by regulatory  agencies,  including  the U.S.  Food  and 
Drug Administration (FDA) and the European Medicines Agency (EMEA). 
Three are acetylcholinesterase inhibitors and the other is memantine, an 
NMDA receptor antagonist. No drug has an indication for delaying or halting 
the progression of the disease.
The recent development of new AChE inhibitors as drugs capable of 
reducing  the  symptoms  of  AD.  Examples  –  tacrine,  donepezil, 
galanthamine,  rivastigmine  through  inhibition  of  the  enzyme 
acetylcholinestetase,  responsible  for  breakdown  of  acetyl  choline  in  the 
neural synapse13.
Although  very  few  drugs  are  currently  approved  by  regulatory 
authorities for treating multi – factorial ailments and disorders of cognition 
such as Alzheimer’s disease, certain plant – derived agents including, for 
example, galantamine (from Galanthus nivalis L.) and rivastigmine (a semi 
– synthetic derivative of physostigmine) are finding an application in modern 
medicine. However, in Ayurveda, the Indian traditional system of medicine, 
which  is  more  than  5000  years  old,  selected  plants  have  long  been 
classified  as  ‘medhya  rasayanas’  from  the  Sanskrit  words  “medhya”, 
meaning  intellect  or  cognition  and  rasayana”,  meaning  “rejuvenation”. 
These plants are used both in herbal and conventional medicine and offer 
benefits that pharmaceutical drugs lack14.
However, these drugs are known to have limitations for clinical use 
due  to  their  short  half  lives  and  /or  unfavorable  side  effects  (elevated 
transaminase, nausea, vomiting, diarrhoea, dyspepsia and etc)15.
So,  it  is  necessary  to  search  for  AChE inhibitors  with  lower  side 
effects from natural resources.  
List of medicinal plants having AChE inhibition
Plant Name Phytoconstituent
Galanthus nivalis - Galanthamine14
Corydalis ternata - Protopine16
Origanum majorana - Ursolic acid17
Salvia (sage) species 
S. Fruticosa,  
S. lavandulafolia,  
S. Officinalis  
Salria santolifolia
- Essential oil18
Melissa officinalis - Essential oil18
Rosemarinus officinalis - Essential oil18
Ursolic acid and AChE inhibition
Ursolic acid, also known as urson, prunol, micromerol, and malol, is a 
pentacyclic triterpenoid compound which naturally occurs in a large number 
of vegetarian foods, medicinal herbs, and other plants.  
Ursolic acid can be used for several pharmacological effects, such 
as, anti-tumor (skin cancer), hepato protective, anti inflammatory (oral and 
topical), anti ulcer, anti microbial, anti hyperlipidemic and anti viral. Ursolic 
acid  and  its  isomer,  oleanolic  acid  both  are  similar  in  pharmacological 
activity.
Ursolic acid inhibits acetylcholinesterase. This the enzyme catalyses 
the  breakdown  of  the  neurotransmitter  chemical  acetylcholine,  which  is 
important  for  effective  cognition  and  reasoning.  The  degeneration  of 
acetylcholine – producing neurons in the brains of people with Alzheimer’s 
disease (AD) has been blamed for the symptom of memory loss associated 
with AD. Thus, sustaining acetylcholine levels may help delay this memory 
loss19. 
Reason for selection of plant P. granatum
In order to find a natural source which has the ursolic acid its one of 
the phytoconstitutents, preliminary literature survey revealed that the leaves 
of Punica granatum contains ursolic acid, one of its constituents.
So  we  planned  to  investigate  the  widely  available  leaves  of 




Siang S.T (1983) stated that dried parts of the plant is used for burns 
in traditional Chinese and Western Medicine as local application20.
Jain S.P et al (1984) reported that fresh paste of the plant was used 
for snakebite as local application21.
Pharmacognosy
Anonymous  (2005)  geographical  distribution,  varieties,  cultivation, 
including soil, propagation, manuring etc have been described in detail22.
Shastri  V.M  et  al  (1996)  determined  ashes  and  mineral  content 
quantitatively by gravimetric and colorimetric methods23.
Pharmacology
Prakash A.O et al (1986) reported that acetone, methanol and hydro 
alcoholic extracts showed no embryotoxic effect (200 mg/kg) in pregnant rat 
by gastric intubation method24.
Microbiology
Anesini  C  et  al  (1993)  reported  that  hot  aqueous  extract  showed 
antimicrobial activity (62.5 mg/ml) against E.coli and A. niger25.
AERIAL PARTS
Pharmacological Activity
Dhawan B.N et al (1977) reported that hydro alcoholic extract parts of 
the plant was used as diuretic (0.063 mg/kg), hypothermic (0.125 mg/kg) in 
rat26.
Microbiology
Aynehchi  Y  et  al  (1982)  reported  the  antibacterial  activity  of  the 
ethanolic extact (100 mg/ml) against P. valgaris, S. paratyphi, B. anthracis 
by agar plate method27.
FLOWERS
Ethnomedical Information
Bellakhar J et al (1991) reported that flowers of the plant was used 
for diarrhoea in Moroccan pharmacopoeia28.
Jafri M.A et al (2000) reported that powdered flower buds was used 
for bronchitis and diabetes29.
Li Y.  et al (2005) reported that flowering part was used for diabetes 
in Unani system of medicine30.
Wang R et al (2006) stated that flower was used locally for grey hair 
of young man in traditional  Chinese medicine and also as an astringent, 
haemostatic31.
Bagri P et al (2008) stated that decoction was used as mouthwash in 
oral and throat inflammation32.
Celik I  et al (2008) reported that flower is consumed worldwide as 
beverage33.
Phytochemistry
Batta A.K et al (1973) isolated crystalline chemical components like 
maslinic acid, asiatic acid 34.
       ASIATIC ACID          MASLINIC ACID
Kirillova  W  et  al  (1988)  reported  the  presence  of  cyanidine, 
delphinidine35.
Huang  T.H  et  al  (2005)  identified  the  presence  of  Ursolic  acid, 
oleanolic acid, gallic acid36,37.
GALLIC ACID        ELLAGIC ACID
Anonymous (2005) mentioned that the presence of pelargonidine 3,5-
di glucoside (a light red dye) used for dying cloth22.
Wang R et al 2006 reported a new compound pomegranate and six 
known compounds namely ellagic acid, 3, 31, 41 – tri – O – methyl ellagic 
acid,  ethyl  brerifolin  carboxylate,  Ursolic  acid, masilinic  acid  and 
daucosterol31.
Jurenka M.T.J et al (2008) reported the presence of  Ursolic acid, 
maslinic acid, styptic acid, gallic acid38.
Pharmacology
Naqvi  A.H  et  al  (1992)  stated  that  the  aqueous  extract  showed 
antiamoebic activity (25 mg / 10 gm, oral)39.
Jafri  M.A  et  al  (2000)  stated  that  hydro  alcoholic  extract  showed 
antidiabetic activity (400 mg/kg, oral) in rats29.
Li  Y.  et  al  (2005)  reported  that  methanolic  extract  was  active  in 
postprandial hyperglycemia (IC50 1.8 mg/ml, oral) in rats30.
Wang R et al (2006) reported that conjugate diene inhibition of LDL 
(0.5 mg/ml, oral)31.
Kaur  G  et  al  (2006)  stated  that  ethanolic  extract  of  showed 
antioxidant and hepatoprotective effect (50 – 150 mg/kg, oral) in mice40.
Bagri  P  et  al  (2008)  reported  that  aqueous  extract  showed 
antidiabetic  activity,  regulation  of  abnormalities  in  lipid  profiles,  oxidative 
stress (250, 500 mg/kg)32.
Celik I et al (2008) reported that flower beverage showed significant 
improvement in degenerative liver disorder33.
FRUIT
Ethnomedical Information
John D et al (1984) stated that tender fruit paste in boiled milk was 
used in dysentery41.
Goh S.H et al (1984) stated that dried fruit  was used in child birth 
disorders in Malaysia42.
Arseculeratne S.N et al (1985) stated that fresh fruit aqueous extract 
was used in dysentery and as a cooling agent43.
Singh Y.N et al (1986) reported that fresh fruit was used in cold and 
running nose44.
Caceres A et al  (1987) stated that dried fruit  aqueous extract was 
used locally in conjunctivitis, wounds, ulcers, sores, bruises, mouth lesions, 
stomatitis, leucorrhea, vaginitis45.
Nagaraju N et al (1990) stated that immature fruit powder was used 
in peptic ulcers46.
Anonymous  (1992)  stated  that  whole  fruit  powder  was  used  in 
diarrhoea and as diet47.
Ghazanfar S.A et al (1993) stated that fruit was used in anthelmintic 
and diarrhoea48.
Desta  B et  al  (1994)  stated  that  shade  dried  fruit  hydro  alcoholic 
extract was used in fertility control49.
Fujita  T  et  al  (1995)  reported  that  fruit  paste  was  used locally  in 
hemorrhoids50.
Navarro F.M et al (1996) stated that shade dried fruit hulls infusion 
was used in infectious diseases51.
Vazquer  F.M  et  al  (1997)  stated  that  dried  fruit  was  used  as  an 
astringent, diuretic, digestive52.
Lamar  A.Z  et  al  (2008)  reported  that  fruit  was  used  in  acidosis, 
dysentery,  diarrhoea,  helminthiasis,  microbial  infections,  hemorrhage, 
respiratory pathologies in Cuban traditional Medicine53.
Pharmacological Activity
Prakash A.O et al (1976) reported that ethanolic extract showed no 
abortifacient and embryotoxic effect (200 mg/kg, oral)54.
Goh S.H et al (1984) reported uterine stimulant activity (0.3 ml) but 
not hypotensive effect (0.1 ml)42.
Kamboj V.P et al (1988) reported anti implantation effect55.
Igea J.M et al (1991) stated allergenic effect56.
Desta  B  (1994)  reported  that  ethanolic  extract  showed  anti 
implantation effect (1.82 gm/kg, i.g)49.
Alkofahi A et al (1999) stated that ethanolic extract showed antiulcer 
activity (400 mg/kg, i.g) in rats57.
Jung S.H et al (2003) reported that methanolic extract showed aldose 
reductase inhibition effect (IC50, 0.27 mg/ml)58.
Vidal  A  et  al  (2003)  reported  that  hydroalcoholic  extract  showed 
antiviral activity (0.4 – 1.2 mg/kg, intranasal)59.
Okamotto J.M et al (2004) reported antidepressant activity in mice60.
Sudeesh S et al (2005) reported that the flavonoid fraction, acetone 
extract showed antioxidant activity (10 mg/kg, i.g)61.
Vinutha  B  et  al  (2007)  stated  that  methanolic  extract  showed  no 
acetylcholinesterase inhibitory (AChE) activity62.
Patel C et al (2008) reported that aqueous extract showed no acute 
and subchronic toxicity (i.p or oral)63.
Lamar A.S et al (2008) stated that hydroalcoholic extract showed no 
genotoxicity53.
Microbiological Review
Konowalchuk J et al  (1976) reported that aqueous extract  showed 
antiviral activity64.
Caceres  A et  al  (1987)  reported that  ethanolic  extract  showed no 
antiyeast and antibacterial activity (30 ml/disc)45.
Desta B (1994) reported that acid ethanolic extract showed antiyeast 
and antibacterial activity (0.2 ml/disc)49.
Menezer S et al (2006) reported that hydroalcoholic extract showed 
antiyeast activity65.
Jurenka  M.T.J  et  al  (2008)  reported  that  hydroalcoholic  extract 
showed antibacterial (dental plaque) activity38.
FRUIT JUICE
Ethnomedical Information
Singh Y.N (1986) stated that fresh fruit juice was used in diarrhoea 
and jaundice44.
Singh V.K et al (1994) stated that fresh fruit juice was used in high 
fever, with loss of senses66.
Khan  M.A  et  al  (2006)  reported  that  fresh  fruit  juice  used  in 
anthelminitic, anaemia, diarrhoea, dyspepsia, tonic67.
Phytochemistry
Mavlyanov S.M et al (1997) reported the presence of delphinidine, 
pelargonidine68.
         
               DELPHINIDINE     PELARGONODINE
Artik  N  et  al  (1998)  determined  the  presence  of  caffeic  acid, 
chlorogenic acid, p – coumaric acid, quinic acid, quercetin, rutin by HPLC69.
RUTIN CHLOROGENIC ACID
       p-COUMARIC ACID     QUINIC ACID
    CAFFEIC ACID    QUERCETIN
Hernadez  F  et  al  (1999)  stated  the  presence  of  delphinidine, 
pelargonidine, cyanidine70.
CYANIDINE        CATECHIN
Gil M.I et al (2000) stated the presence of punicalagin71.
Teresa  S.D.P  et  al  (2000)  reported  catechin,  epicatechin, 
epigallocatechin 3 – gallate72.
Poyrazoglku  E  et  al  (2002)73,  Lansky  E.P  et  al  (2007)74,  Jurenka 
M.T.J (2008)38, were reported aliphatic organic acids (citric acid) phenolic 
compounds (chlorogenic acid) flavonols (quercetin, catechin).
Pharmacology
Gil M.I et al (2000) reported antioxidant activity71.
Aviram M et al (2000) stated antioxidant, antiatherogenic, and platlet 
aggregation inhibition activity75.
Kalpan  M  et  al  (2000)  reported  antioxidant,  antiatherogenic,  and 
cholesterol inhibition activity in mice76.
Noda  Y  et  al  (2002)  stated  that  the  ethanolic  extract  showed 
superoxide radical scavenging activity77.
Kim N.D et al (2002) reported chemopreventive and adjuvant therapy 
in human breast cancer78.
Toi M et al (2003) stated antiangiogenic activity79.
Kawaii S et al (2004) reported differentiation promotion effect80.
Van  Elswijk  D.A.  et  al  (2004)  reported  that  crude  fermented  and 
unfermented juice showed antiproliferative activity81.
Herber D et al (2007) stated antioxidant activity, dietary supplement82.
Jurenka  M.T.J  et  al  (2008)  reported  for  the  treatment  of 
hyperlipidemia,  hypertension,  prostate  cancer,  diabetes,  atherosclerosis, 
carotid artery stenosis, Alzheimer’s disease38.
FRUIT (PEEL, RIND, PERICARP)
Ethromedical Information
Latorre  D.L  et  al  (1977)  stated  that  aqueous  extract  used  in 
menstrual disorder83.
Singh  Y.N  et  al  (1986)  reported  that  aqueous  extract  used  in 
diabetes44.
Mascolo N et al (1987) reported that aqueous extract  showed anti 
inflammatory activity84.
Bellakhdar J et al (1991) stated that pericarp used as an antiulcer, 
hypoglycemiant,  G.I  disorder  and  also  as  vaginal  antiseptic  as  local 
application28.
Heinrich M et al, reported its use in G.I disorders85.
Pillai N.R. et al (1992) was reported antidiarrhoeal activity86.
Defeo V et  al  (1992) stated that  decoction used as an astringent, 
anthelmintic, febrifuge87.
Bhattarai  N.K et al (1993) stated that decoction used in diarrhoea, 
dysentery88.
Perez  C  et  al  (1994)  stated  that  decoction  used  in  urinary  and 
respiratory tract infections89.
Alkofalhi  A  et  al  (1996),  Ahmed I  et  al  (2001)  were  reported  that 
infusion used in diarrohea, dysentery90.
Sudeesh S et  al  (2003)  reported that  pericarp used for  diarrhoea, 
dysentery,  stomachic,  colitis,  piles,  uterine  disorders,  cardiotonic, 
astringent61.
Phytochemistry
Tanaka T et al (1990) determined the structure of granatin – A, B91.
Satomi  H  et  al  (1993)  reported  the  presence  of  casuarinin, 
gallaglydilactone, pedunculagin, tellimagrandin92.
     CASUARININ     GALLAGLYDILACTONE
     PEDUNCULAGIN    TELLIMAGRANIDIN
Poyrazoglku E et al (2002) stated the presence of gallic acid73.
Noda  Y  et  al  (2002)  reported  the  presence  of  delphinidine, 
pelargonidine, cyanidine77.
Van  Elswijk  D.A.  et  al  (2004)  reported  the  presence  of  luteolin, 
quercetin, kaempferol81.
Pharmacology
Dhawan  B.N  et  al  (1958)  reported  that  aqueous  extract  showed 
uterine stimulant activity in rats93.
Gujral M.L et al (1960) stated antifertility activity94.
Kim  N.D  et  al  (1974)  stated  that  methanolic  extract  showed 
anthelmintic effect (12 mg/kg)95.
Mascolo N et al (1987) reported that ethanolic extract showed weak 
antiinflammatory activity (100 mg/kg)84.
Sato A et al (1990) stated that hot aqueous extract showed antitumor 
effect (120 mg/kg)96.
Pillai  N.R  et  al  (1992)  reported  hydroalcoholic  extract  showed 
antidiarrhoeal activity (500 mg/kg, i.g)86.
Hukkeri  V.I  et  al  (1993)  stated  that  aqueous  extract  showed 
anthelmintic activity97.
Khennouf S et al (1999) reported antiulcer activity in rats98.
Roos  R.G  et  al  (2001)  stated  that  powder  of  the  plant  showed 
immune stimulant effect (100 mg/kg, i.g) in rabbits99.
Noda Y et al (2002) stated that ethanolic extract showed antioxidant 
activity (IC50 10 mg/ml)77.
Murthy K.N.C et al (2002) reported that methanolic extract showed 
hepatoprotective activity (50 mg/kg)100.
Aslant M et al (2003) stated antidiabetic activity (500 mg/kg) in rats101.
Bafna  P  et  al  (2003)  reported  that  methanolic  extract  showed 
antimotility, antiulcer, anti diarrhoeal activity in animals102.
Ajaykumar K.B et  al  (2005) stated that methanolic  extract  showed 
gastro protective effect (500 mg/kg)103.
Qnais  P  et  al  (2007)  reported  that  aqueous  extract  showed 
antidiarrhoeal activity104.
Sestili, P et al (2007) stated cytoprotective effect105.
Microbiological Review
Naovi S.A.H et al (1991, 1992) reported that aqueous and ethanolic 
extract  showed anti  bacterial  activity (10 mg/ml) and antiamoebic activity 
(10mg/10gm)106.
Miranda D et al (1993) stated that petroleum ether extract showed 
antibacterial activity107.
Perez  C  et  al  (1994)  reported  that  hot  aqueous  extract  showed 
antibacterial activity89.
Goto  W et  al  (1996)  stated  that  aqueous  extract  showed  antiviral 
activity (1mg /ml)108.
Prasanth  D  et  al  (2001),  Ahmed  I  et  al  (2001)  were  reported 
equivocal effect in antibacterial activity109.
Ahmed I et al  (2003) stated that acetone or methanol  extract  was 
showed anti – MRSA activity110.
Leaves
Ethnomedical information 
Arnason  T  et  al  (1980)  stated  that  hot  aqueous  extract  used  in 
women’s disorder as local application111.
Ilham M et al (1995) reported that infusion used as tonic112.
Singh  V.K  et  al  (1996)  stated  leaf  extract  used  in  menstruration 
disorders66.
Nadkarni K.M et al (1954)113, Jafri M.A et al (2000)29, Ross R.G et al 
(2001)99 were reported that paste used in conjunctivitis as local application.
Nadkarni  K.M et al  (1954) stated that juice used as an astringent, 
styptic113.
Phytochemistry
Elgamal M.H.A et al (1965) reported the presence of  ursolic acid, 
oleanolic acid, betulic acid114.
URSOLIC ACID OLEANOLIC ACID
Fayez  M.B.E  et  al  (1967)  reported  the  presence  of  ursolic  acid, 
betulic acid, β-sitosterol115.
Robert M.F et al (1967) stated the presence of unstable alkaloid [2-
(2-propenyl)-∆ ’ – Piperideine]116.
Gawienoski A.Metal (1969) reported the presence of pregnenolone117.
Pavanasasivam G et  al  (1974)  reported  the  presence  of  betulinic 
acid118.
Tawfik  N.I et  al  (1978) stated the presence of  alkaloids,  carotene, 
coumarins119.
Tanaka T et al (1985) reported the presence of corilagin, granaitin – 
A, B, strictinin, punicafolin120.
Kirillova V.V et al (1988) stated the presence of delphinidine35.
Nawwar  M.A.M  et  al  (1994)  reported  the  presence  of  brevifolin, 
punicafolin, granaitin-B, xanthoxylin, ellagic acid121.
Nawwar M.A.M et al (1994) reported the NMR structure analysis of 
apigenin, luteolin, piperidine alkaloids122.
Anonymous (2005) mentioned reported the presence of ursolic acid, 
and betulic acid22.
Lansky  E.P.  et  al  (2007)  mentioned  the  presence  of  apigenin, 
brevifolin carboxylic acid 10-mono phosphate sulphate, apigenin – 4’-O-β  - 
glucopyranoside,  luteolin  –  4’-O-β-glucopyranoside,  luteolin  –  3’-O-β  - 
glucopyranoside, luteolin – 3’-O-β  - xylopyranoside, puniclain, punicalagin, 
corilagin,  punicafolin,  piperidine  alkaloids  (N-(2’,5’  –  Dihydroxy  phenyl 
pyridium chloride)74.
PUNICAFOLIN   PUNICALIN
   PIPERIDINE ALKALOID   APIGENIN
BREVIFOLIN CARBOXYLIC ACID    LUTEOLIN 3- PYRANOSIDE
Pharmacological
Lei F.X.N et al (2007) reported antiobesity action123.
Microbiology
Collier  W.A.  et  al  (1949)  stated  that  the  saline  extract  showed 
antibacterial activity in agar plate method124.
Misas  C.A.J  et  al  (1979)  stated  that  aqueous,  ethanol,  acetone 
extracts showed antibacterial activity125.
Ayudhaya T.D et al (1987) stated that methanolic extract was inactive 
against P.falciparum126.
Ilham M et al (1995) reported that ether extract  was inactive in tumor 
promotion effect in cell culture method in mouse112.
Alkofahi A et al (1997) reported that ethanolic extract of shade dried 
leaf  and  stem  showed  antibacterial,  anti  yeast  activity  in  agar  plate 
method127. 
Seed
John D (1984) reported that mature seeds used in hemorrhoids41.
Okamoto  J.M  et  al  (2004)  stated  that  seed  oil  used  as  an 
antioxidant60.
Anonymous (2005) mentioned that seed oil used in stomachic22.
Phytochemistry
Heftmann E et al (1966) identified the presence of esterone128.
Ahmed R et al (1995) isolated and identified the presence of Ursolic 
acid129.
 Schubert S.Y et al (1999) reported punicic acid, linoleic acid, stearic 
acid, palmitic acid and Oleic acid130.
Kim N.D et al (2002) reported the presence of 17 – α – estradiol, γ – 
tocopherol78.
PUNICIC ACID
Lansky  EP  et  al  (2007)  mentioned  that  the  presence  β-Sitosterol 
testosterone, 17α estradiol, tocopherol, cereboside74. 
β - SITOSTEROL
Pharmacology
Dean P.D.G. et. Al (1971) stated uterine relaxation, esterogenic effect 
(0.2 ml, 0.4 ml)131.
Lee J.W et  al  (1992)  reported  that  aqueous  extract  showed  weak 
hepatoprotective effect (1mg/ml)132.
Abd El Wahab et al (1998) stated that seed oil showed esterogenic, 
androgenic effect (15 mg / Kg., 40 mg/kg; s.c)133.
Das  A.K  et  al  (1999)  reported  that  methanolic  extract  showed 
antidiarrhoeal activity (200 mg/kg, i.g.)134.
Schubert  S.Y et al (1999) stated that seed oil  showed antioxidant, 
eicosanoid enzyme inhibition effect125.
Van  Elswijk  D.A.  et  al  (2004)  reported  that  seed  oil  showed 
antiproliferative effect in human breast cancer81.
Selvasubramanian S. et al (2000) stated that seed powder showed 
anti nematodal effect (0.75gm/kg)135.
Kwak H.M et al (2005) reported that seed husk showed β-secretase 
inhibitory activity136.




Singh  V.P  et  al  (1980)  stated  that  aqueous  extract  used  in 
leucorrhea, leprosy, menorrhagia137.
Jafri M.A et al (2000) reported that decoction used in dysentery29.
Bharadwaj  S.  et  al  (2003)  stated  the  bark  used  for  dysentery  in 
Mizoram tribal medicine138.
Anonymous (2005) mentioned that decoction used as taenicide22.
Phytochemistry
Tanaka T et al (1985)120, Neuhofer H et al (1993)139 Lansky E.P et al 
(2007)24 were reported the presence of punicalin, punicalagin, punigluconin, 
pelletierine, punicacortein – A, B, C, D120.
Chauhan  D  et  al  (2001)  stated  the  presence  of  quercetin, 
pelargonidine, ellagic acid140.
Anonymous (2005) mentioned the presence of friedlin, betulic acid, 
pelletierine22.
Pharmacology
Tripathi S.M et al (2004) reported the bark showed enzyme inhibition 
AChE by molluscicidal agent141.
Root
Ethnomedical Information
Caius J.F et al (1923) Darivas V et al (1989) stated that hot aqueous 
extract used anthelmintic142.
Yazicioglu A et al 1996 reported that decoction used for removal of 
kidney stones143.
Bharadwaj et al (2003) stated its use in dysentery133.
Phytochemistry
Tanaka T et al (1985)120, Neuhofer H et al (1993)134, Lansky E : P et al 
(2007)74, Jurenka M.T.J et al (2008)38 reported the presence of punicalin, 
punicalagin, punicacortein – A, B, C, D, pelletierine alkaloids.
 
 PUNICACORTEIN- A PELLETIERINE ALKALOIDS
Pharmacology
Sousa  P.D  et  al  (1974)  reported  that  aqueous,  ethanolic  extract 
showed molluscicidal activity (1000 ppm)144.
Singhal  K.C  et  al  (1984)  stated  that  chloroform  extract  showed 
anthelmintic effect in mice145.  
Desta  A.B  et  al  (1995)  reported  that  powder  showed  taenicide 
effect146.
Microbiological Review
Kurokawa M et al (1993) reported that hot aqueous extract showed 
antiviral activity.  (0.5, 1 mg/ml) in mice147. 
Acute toxicological studies
Michael,  A.S.,  et  al  (1956)  mentioned  Artemia  Salina  as  a  test 
Organism for a bioassay148. 
Vanhaecke P., et al (1981) mentioned that a short – term toxicity test 
with Artemia nauplil149. 
Sleet  R.B.,  et  al  (1983)  Improved  Methods  for  harvesting  and 
counting  synchronous  populations  of  Artemia  nauplii  for  use  in 
developmental toxicology150.
Sadhana Sathaye et al (2001) mentioned Brine shrimp lethality test a 
bench top bioassay was carried out to screen the toxic potential of herbal 
preparations.   Number  of  deaths  of  larvae  was  taken  as  bioactivity  or 
toxicity151. 
Screening Methods of Ache Inhibitory Activity
Chung Y.K et al (2001) reported that the AChE assay was performed 
according to the colorimetric method of Ellman et al using acetyl thiocholine 
iodide as a substrate17.
Sung S.H et al (2002) reported that the AChE assay was performed 
according to the colorimetric method of Ellman et al using neostigmine as 
positive control152. 
Gupta R.K (2004) mentioned that AChE inhibitory activity done by 
Ellman method153.
Nino J. et al  (2006) reported that the AChE assay was performed 
according  to  the  colorimetric  method  of  Ellman  et  al  using  esering  as 
positive control14. 
Adsersen A et al (2007) reported that the AChE and BChE inhibitory 
activity was detected by a TLC bioautographic assay and the concentration 
of the isolated compounds that inhibited the enzyme activity by 50% (IC50) 
was  determined  by  a  microtitre  plate  assay  based  on  Ellman  method, 
Galanthamine HBr was used as a positive control154.
Vinutha B et al (2007) reported that the AChE inhibition assay was 
carried out as per the method of  Atta-ur-Rahman et al  (2001),  and TLC 
bioautography  for  AChE  inhibition  was  performed  as  per  Martson  et  al 
(2002), eserine was used as positive control62.
AIM AND OBJECTIVE
Aim
To study the pharmacognostic,  phytochemical  and invitro study on 
acetylcholinesterase  inhibitory  activity  of  leaves  of  Punica  granatum L.  
Var: Ganesh.  Family Punicaceae.
Objective
  The objective of the study was divided into three parts.
Part – I
Pharmacognostic Studies
 Identification, collection and authentification of leaves of P. granatum.
 Detailed  pharmacognositc  study  includes  morphological  study, 
microscopical study and quantitative microscopy
Part – II
Preliminary Phytochemical Studies
 Preliminary phytochemical analysis of the leaf powder and different 
extracts.
 Identification and estimation of  ursolic  acid  by TLC and HPLC for 
different extracts.
Part III
♦ Acute toxicological study 
To perform BSLB (Brine Shrimp Lethality Bioassay) as a preliminary 
  assessment of the toxicity of for different extracts of               
  P. granatum L.
♦ Acetylcholinesterase Inhibitory Activity
Part – A
Standardization & Validation of Ellman method which includes
 Determination of Acetylcholinesterase concentration.
 Determination of substrate (ATCI) concentration.
 Determination of Ellman reagent (DTNB) concentration.
 Determination of pH maxima.
 Determination of Temperature maxima.
Part – B
 To evaluate the effect of the extracts having  ursolic acid for invitro 
acetylcholinesterase inhibitory activity.




MACROSCOPICAL STUDIES OF THE LEAVES OF 
Punica granatum Linn22,155,156,157,158,159.
Punica granatum Linn is a dicotyledonous plant belonging to the family 
Punicaceae.
On the basis of the structure of the ovary and the typical fruit (the balusta), Punica 





Division : Magno liophyta
Class : Magno liopsida













Tamil : Madulai, Madalai Uôçû[, UôRû[










Considered  to  be  Iran,  Afghanistan,  Baluchistan  wild  in  the  warm  valleys  of 





P.granatum is a shrub or small tree, 5 – 10m high, dicotyledonous plant belonging 
to the family punicaceae. It is a subtropical fruit tree, growing best in semi – acrid climate 
where  cool  winters  and hot  summer prevail.  It  grows  under  a wide  range of  climatic 
conditions and is planted upto 350N in USA. It stands considerable frost and is injured 
only  when  the temperature  goes  below        –  110C.  It  thrives  even under  desert 
conditions. Although it is highly drought resistant, the pomegranate bears well only under 
irrigation (Plate-1,4) (Fig-1).
Description of the plant22,155,161
Leaves: 2-8  cm  long  oblong  or  obovate  shinning  above,  bright  
  green  beneath,  opposite,  glabrous,  minutely  pellucid  –  
  punctuate (Plate-3,6,7).
Flowers : Scarlet  red  or  sometimes  yellow,  3.7  –  5cm  long  mostly  
  solitary,  some  times  2  –  4  together,  stamens  very  
  numerous  inserted  on  the  carlyx  below  the  petals  at  
  various levels (Plate-2).
Fruits : Globose, crowned by the persistent calyx (Plate-5).
Rind : Coriaceous  and  woody,  interior  septate  with  
  membranous walls, containing numerous seeds.
Seeds : Angular with red, pink or whitish fleshy testa.
Bark : 5  –  10  cm  long  and  1-3  cm  wide  root  bark  consists  of  
  irregular,  curved,  flattish  or  recurred  fragments.The  outer  
  surface  is  rough,  earthy  yellow  with  darker  patches;  the  
  inner  surface  is  smooth  and  yellow,  with  irregular,  darker,  
  brown  blotches;  the  fracture  is  short.  The  Stem  Bark  is  in  
  straighter  channeled  pieces  or  in  quills,  the  outer  surface  
  shows  occasional  shallow,  longitudinal  furrows  and  pale  
  bands of cork22.
Varieties22













Deep loamy soil preferably calcareous soil containing time nodules and tolerates 
soil alkalinity.
Propagation and culture
Pomegrante is propagated by seed, seedlings and hard wood cuttings.
Manuring
Well  –  rotted,  old  farmyard  manure  mixed  with  ashes,  groundnut  cake  is 
advantageous.
SECTION – B




The plant specimens were collected from Department of Horticulture Tamil Nadu 
Agricultural  University,  Madurai,  Tamil  Nadu  during  August  2008.  Care was  taken to 
select healthy plants and for normal organs. The leaves were cut and removed from the 
plant and fixed in FAA (Formalin-            5 ml + Acetic acid – 5 ml + 70% ethyl alcohol-90  
ml). After 24 hrs of fixing, the specimens were dehydrated with graded series of tertiary-
butyl alcohol. Infiltration of the specimens was carried by gradual addition of paraffin wax 
(melting point 58-600c), until TBA solution attained super saturation. The specimens were 
cast into paraffin blocks.
Sectioning
The  paraffin  embedded  specimens  were  sectioned  with  the  help  of  rotary 
microtome. The thickness of the sections was 10-12 µm. After dewaxing the sections 
were stained with toluidine blue. Since toluidine blue is a polychromatic stain, the staining 
results were remarkably good and some cyto chemical reactions were also obtained. The 
dye rendered pink color to the cellulose walls, blue to the lignified cells, dark green to 
suberin, violet to the mucilage, blue to the protein bodies etc., Where ever necessary, 
section were also stained with safranin and fast-green and potassium iodide (for starch).
For studying the stomatal morphology, venation pattern and trichome distribution, 
paradermal sections (sections taken parallel to the surface of leaf) as well as clearing of 
leaf with 5% sodium hydroxide and epidermal peeling by partial maceration employing 
jeffrey’s  maceration  were  prepared.  Glycerine  mounted  temporary  preparations  were 
made for macerated/cleared materials.
Photomicrographs
Microscopic  descriptions  of  tissues are  supplemented  with  micrographs where 
ever necessary. Photographs of different magnifications were taken with Nikon labphoto 2 
microscope unit. For normal observations bright field was used. For the study of crystals, 
starch grains and lignified cells,  polarized light  was employed.  Since these structures 
have  birefringent  property,  under  polarized  light  they  appear  bright  against  dark 
background.
MICROSCOPY OF LEAF
The leaf has thick semicellular midrib and thin lamina. In cross sectional view, the 
lamina exhibites distinct dorsiventral symmetry.
Midrib (Plate-8,8A), (Fig-2,2A)
Size : 400 µm thick in vertical plane
600 µm wide in horizontal plane.
has wide dorsal concavity and abaxial side hemispherical.
Epidermis (Plate-9,9A,9B)
Small elliptical  cells, adaxial  in surface view, the cells are either rectangular or 
polygonal  with  slightly  wavy  anticlinal  walls.   In  the  cells  stained  with  safranin  thin 
cuticular striations are seen prominently, which are parallel to each other.
Abaxial epidermis
Stomata anomocytic  (Ranunonculaeous),  no distinct  subsidiary  cells  are seen. 
Walls are undulate, amoeboid outlined, with deep folds in stomata.  The guard are cells 
are oblong, eliptic and have narrow slit like aperture.
Vascular bundle 
Simple, wide and bowel shaped with adaxial cavity.
Xylem
Dense parallel lines, narrow thick walled angular in out line.
Phloem
Thin, present in abaxial layer.
Lamina
80µm thick and has thick adaxial  epidermis which consists of wide rectangular 
cells 20 μm in thick (Plate-10,10A,10B).
Mesophyll 
Single layer adaxial palisade cells, 20-30 µm in height, spongy parenchyma about 
five layers of large, circular closed arranged cells.
Idioplast
Specially modified, dilated cavities bearing calcium oxalate crystals are frequently 
seen. Crystals may be prismatic (20-40 µm thick) or druses (30µm thick).
Venation Pattern (Plate-11,11A)
Secondary and tertiary veins are uniformly thin and wavy.  Some vein islets are 
distinct.  The vein terminations are short, straight ends or simple.
Petiole (Plate-12,12A,12B)
  The proximal end of petiole side semi circular with wide abaxial, and concavity two 
short and thick lateral wings, 1.2mm in vertical axis and 1.4mm in horizontal axis.
Distal end
The distal end of petiole has deep ‘V’ shape adaxial groove, long and prominent 
wings, which is 1mm vertical, 1.25mm horizontal, epidermal layer of small squarish cells. 
Ground tissue is parenchymatous which are angular thick walls and compact.  Vascular 
stand is single, arc shaped, having densed parallel files of long, narrow xylem elements 
which are thick walled with narrow lumen. Phloem prominent  in the lower  part  of  the 
xylem, vascular strand is 600µm wide, 250µm thick.




Odour - Agreeable Odour
Taste - Tasteless
The powder microscopy of the leaf powder reveals the following charaters (Fig-3)
 Epidermal cells with thin & slighty wavy anticlinal walls.
 Anomocytic stomata (Ranunculaceous)
 Spongy parenchyma with prismatic crystals
 Xylem, phloem vessels
 Fragments of leaf  
SECTION – C
QUANTITATIVE MICROSCOPY FOR LEAVES OF 
P. grantum L.
Microscopic Schedules167,168,169,170,171 
The vein islet number, vein terminal number, stomatal number and stomatal index 
were determined on fresh leaves using standard procedures.
A. Vein islet number and Vein terminal number
The term vein islet  in used to denote the minute area of photosynthetic  tissue 
encircled by the ultimate divisions of the conducting strands. The number of vein islets 
per sq. mm., area is called vein islet number.
Vein terminal number may be defined as the number of vein terminals present in 
one sq., mm. area of the photosynthetic tissue.
Determination of Vein Islet Number and Vein Termination Number
Leaf lets were cleared in chloral hydrate, stained and mounted on a slide.
A camera lucida is  set  up and by means of  a stage micrometer  the paper  in 
divided into squares of 1mm2 using a 16mm objective.  The stage micrometer is then 
replaced by the cleared preparation and the veins are traced in four contiguous squares, 
either in a square 2mm x 2mm (or) rectangle 1mm x 4 mm.
When counting, it is convenient to number each vein-islet on the tracing.    Each 
numbered area must be completely enclosed by veins, and those which are incomplete 
are excluded  from the count  if  cut  by the top and left-hand sides  of  the  square (or) 
rectangle but included if cut by the other two sides.
Ten readings for vein islet and vein termination number were recorded.   
Table - 1
VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER OF 
P. granatum L.











Range Minimum Average Maximum
Vein islet Number 24 31 37
Vein Termination 
Number 21 24 28
Stomatal Number
Stomatal number is defined as the number of stoma present in one square mm 
area of the photosynthetic tissues.
Method
Using fresh leaves, replicas of leaf surface may be made which are satisfactory 
for  the  determination  of  stomatal  number  and  stomatal  index.   An  approximate  50% 
gelatin and water gel is liquified on a water – bath and smeared on a hot slide.  The fresh 
leaf is added, the slide inverted and cooled under a tap and after about 15-30 min the 
specimen is stripped off.















Range Minimum Average Maximum
Lower epidermis 187 205 217
B. Stomatal Index
                 It is the percentage, which the numbers of stomata from the total number of 
epidermal cells, each stoma being counted as one cell.
I, Stomatal index = S/S+E x 100
Where         S = Number of stomata per unit area
                   E= Number of epidermal cells in the same unit area
Determination of Stomatal Index
The procedure adopted in the determinations of stomatal number was observed 
under high power (45 x).The epidermal cells and the stomata were counted. From these 
values the stomatal index was calculated using the above formula.
Table – 3
STOMATAL INDEX
















QUANTITATIVE SCHEDULES FOR LEAVES OF               
P. granatum L.
Ash Value
The ash values were determined by using air dried powder of the leaf as per the 
official method.
Total ash
Two grams of the air  dried leaf  powder was accurately weighed in a platinum 
crucible separately.  The powder was scattered into a fine even layer on the bottom of the 
crucible and incinerated by gradually increasing the temperature not exceeding 450oc, 
until  free  from carbon.   Then  it  was  cooled  and  weighed  for  constant  weight.   The 
percentage of ash with reference to the air dried powder was calculated.
Water soluble Ash
The ash obtained from the total ash procedure was boiled with 25 ml of water for 5 
minutes and the insoluble matter was collected on an ash less filter paper and washed 
with hot water.  Then it was ignited for 15 minute at a temperature not exceeding 450oc. 
The weight of the insoluble matter was subtracted from the weight of the total ash.  The 
difference in weight represents the water soluble ash.  The percentage of water soluble 
ash was calculated with reference to the air dried powder.
Acid insoluble ash
The ash obtained from the total ash was boiled for five minutes with 25 ml of dilute 
hydrochloric acid.  The insoluble matter was collected in a tarred sintered glass crucible. 
The residue was washed with hot water,  dried and weighed.  The percentage of acid 
insoluble ash with reference to the air dried drug was calculated. 
Table - 4 
ASH VALUES FOR THE LEAVES OF P. granatum L.
 Observation 
Number Total Ash (%)
Acid Insoluble ash 
(%)
Water soluble Ash 
(%)
1 11.45 1.46 -
2 11.26 1.52 -
3 10.90 1.50 -
4 11.12 1.53 -
5 11.49 1.56 -
6 10.80 - 2.96
7 11.20 - 2.60
8 10.91 - 2.52
9 11.12 - 3.02
10 10.78 - 2.90
Range
Minimum 10.78 1.46 2.52
Average 11.10 1.51 2.8
Maximum 11.49 1.56 3.02
Determination of Loss on Drying
For  the  determination  of  loss  on  drying,  the  method  described  by  wallis  was 
followed.
One gram of the powdered leaf was accurately weighed in a tarred Petri dish, 
previously dried under the conditions specified in IP ’96. The powder was distributed as 
evenly as practicable, by gentle sidewise shaking.  The dish was dried in an oven at 100 
– 1050 c for 1 hour.  It was cooled in a desiccator and again weighed.  The loss on drying 
was calculated with reference to the amount of the dried powder taken.
Table - 5
PERCENTAGE LOSS ON DRYING FOR THE LEAVES OF P. granatumL.
Observation Number







Material Minimum Average Maximum
Leaf 8.50 8.82 9.10
Extractive Values 
By using solvents successively with increasing order of polarity172
Five grams of the coarsely powdered leaf was extracted continuously in soxhlet 
apparatus  for  six  hours  individually,  separately  with  solvents  of  increasing  order  of 
polarity. After six hours the solvents was removed and evaporated to dryness in a tarred 
flat bottomed shallow dish, dried at 105oc and weighed. The percentage of the individual 
solvent soluble extractive value was calculated with reference to the air dried powder.
Table – 6










SECTION – A 
PHYTOCHEMICAL STUDIES 
FOR THE LEAF OF P.granatum
The plant  P. granatum L. was collected from Department of Horticulture Tamil 
Nadu Agricultural University, Madurai, in Tamilnadu during the first week of August and it 
was Authenticated by the Taxonomist and Horticulturist. The leaves portion was washed 
thoroughly and dried in shadow. The shadow dried leaves were powdered separately and 
then subjected to the following preliminary phytochemical studies.
ORGANOLEPTIC EVALUATION 
Nature of the Powder : Coarse
Colour : Green
Odour : Distinct odour
Taste : Taste less
Shaken with Water : No Frothing occurs
Pressed in between two filter paper : No oily mark on the paper.
PHYTOCHEMICAL STUDIES FOR THE LEAF POWDER AND 
EXTRACTS OF P. granatum L.173,174,175,176
Powdered Materials and their individual extracts obtained from different increasing 
polarity were subjected to the following chemical test and the results were presented in 
the table.
Test for Alkaloids
Various procedures to liberate alkaloids
 Powdered drug was mixed thoroughly with 1 ml of 10% ammonia solution and 
then extracted for 10 minutes with 5 ml methanol, under reflux.  The filtrate was 
then concentrated.
 Powdered drug was mixed thoroughly with 1 ml of 10% sodium carbonate solution 
and then extracted for 10 minutes with 5 ml methanol, under reflux.  The filtrate 
was then concentrated.
 Powdered drug was ground in a mortar  for  about  1 minute with  2 ml  of  10% 
ammonia solution and then thoroughly mixed with 7 gram basic aluminum oxide. 
The mixture was then loosely packed in to a glass column and 10 ml chloroform 
was added, eluted, dried and methanol was added.
 Powdered drug was shaken for 15 minute with 15 ml of 0.1 N sulphuric acid and 
then filtered.  The filter was washed with 0.1 N sulphuric acid to a volume of 20 ml 
filtrate;  1  ml  concentrated  ammonia  was  then  added.   The  mixture  was  then 
shaken  with  two  portions  of  10  ml  diethyl  ether.   The  ether  was  dried  over 
anhydrous sodium sulphate, filtered and evaporated to dryness and the resulting 
residue was dissolved in methanol.
 Powdered drug was mixed with one gram of calcium hydroxide and 5 ml of water, 
made into a smooth paste and set aside for 5 minutes.  It was then evaporated to 
dryness in a porcelain dish on a water bath.  20 ml of 90% alcohol was added, 
mixed well and then refluxed for half an hour on a water bath.  It was then filtered 
and the alcohol was evaporated.  To that dilute sulphuric acid was added.
The above made extracts were tested with various alkaloid reagents and the results 
were as follows.




2.  Dragendorff’s reagent - Reddish brown precipitate
3. Hager’s reagent - Yellow precipitate
4. Wagner’s reagent - Reddish brown precipitate
Test for purine group (Murexide test)
The residue obtained after the evaporation of chloroform was treated with 1 ml of 
hydrochloric  acid  in  a  porcelain  dish  and 0.1g of  potassium chlorate  was  added and 
evaporated to dryness on water bath.  Then the residue was exposed to the vapours of 
dilute ammonia solution.




The aqueous extract of the powdered material was treated with alcoholic solution 
of  α - naphthol in the presence of sulphuric acid.  
Purple colour was obtained indicating the presence of carbohydrates.
 Fehling’s test
The aqueous extract of the powdered material was treated with Fehlings I and II 
solution and heated on boiling water bath.  
Reddish brown precipitate was obtained indicating the presence of free reducing 
sugars.
 Benedict’s test
The aqueous extract of the powdered drug was treated with Benedict’s reagent 
and heated over a water bath.  





200 mg of the powdered drug was extracted with 5 ml of dilute sulphuric acid by 
warming on a water bath, filtered and neutralised with 5% sodium hydroxide solution. 
Then 0.1 ml of  Fehlings  solution A and B were added,  until  it  becomes alkaline  and 
heated on a water bath for 2 mts.
 Test B
200  mg  of  the  powdered  drug  was  extracted  with  5  ml  of  water  instead  of 
sulphuric acid. Boiled and equal amount of water was added instead of sodium hydroxide 
solution.  Then 0.1 ml of Fehlings solution A and B were added, until it becomes alkaline 
and heated on a water bath for 2 mts.
The quantity of red precipitate formed in test A is greater than in test B indicating 
the presence of glycosides.
 Anthraquinones
 Borntrager’s test
The powdered leaf was boiled with dilute sulphuric acid, filtered and to the filtrate 
benzene was added and shaken well.  The inorganic layer was separated and ammonia 
solution was added slowly.
No color reaction was observed in ammoniacal layer indicating the  absence of 
anthracene derived glycosides.
 Modified Borntrager’s test
About  0.1  gram  of  the  powdered  leaf  was  boiled  for  two  minutes  with  dilute 
hydrochloric acid and few drops of ferric chloride solution was added, filtered while hot 
and cooled.  The filtrate was then extracted with benzene and the benzene layer was 
separated.  Equal volume of dilute ammonia solution was added to the benzene extract 
and shaken well.
No color was observed in ammoniacal layer indicating the absence of anthracene 
derived glycosides. 
Test for cyanogenetic glylosides
Small quantity of the powdered leaf was placed in a stoppered conical flask with 
just sufficient water to cover it.  A sodium picrate paper strip was inserted through the 
stopper so that it was suspended in the flask and it was set aside for 2 hours in a warm 
place.
No change in the colour of the sodium picrate paper was observed indicating the 
absence of cyanogenetic glycosides
 Test for cardiac glycosides
 Keller Killiani test
About 1 gram of the powdered leaf was boiled with 10 ml of 70% alcohol for two 
minutes, cooled and filtered.  To the filtrate 10 ml of water and 5 drops of solution of lead 
sub acetate were added and filtered.  The filtrate was then extracted with chloroform and 
the  chloroform  layer  was  separated  and  evaporated  to  dryness.   The  residue  was 
dissolved in 3 ml of glacial acetic acid containing a trace of ferric chloride. To this 3 ml of 
concentrated sulphuric acid was added to the sides of the test tube carefully.
No reddish brown layer acquiring bluish green color after standing was observed 
indicating the absence of deoxy sugars of cardiac glycosides.
 Raymond Test
To the alcoholic extract of the leaf, hot methanolic alkali was added.
           No Violet color was produced indicating the absence of cardiac glycosides.
 Legal’s Test 
To the alcoholic extract of the powdered drug, pyridine and alkaline sodium nitro 
pruside solution were added.
           No blood red color was formed indicating the absence of cardiac glycosides.
Coumarin glycosides 
A small amount of powdered leaf was placed in test tube and covered with a filter 
paper  moistened  with  dilute  sodium  hydroxide  solution.   The  covered  test  tube  was 
placed on water bath for several minutes.  Then the paper was removed and exposed to 
UV light.
No  green  fluorescence  was  observed  indicating  the  absence of  coumarin 
glycosides.
Test for Phytosterols
The powdered leaf was first extracted with petroleum ether and evaporated.  The 
residue obtained was dissolved in chloroform and tested for sterols.
 Salkowski Test
Few drops  of  concentrated  sulphuric  acid  were  added  to  the  above  solution, 
shaken well and set aside.
The chloroform layer of the solution turned red in color indicating the presence of 
sterols.
 Libermann – Burchard’s Test
To the chloroform solution few drops of acetic anhydride was added and mixed 
well 1 ml of concentrated sulphuric acid was added through the sides of the test tube and 
set aside for a while.
A brown ring was formed at the junction of the two layers and the upper layer 
turned green indicating the presence of sterols.
Test for Saponins
About 0.5 gram of the powdered leaf was boiled gently for 2 minute with 20 ml of 
water and filtered while hot and allowed to cool.  5 ml of the filtrate was then diluted with 
water and shaken vigorously.  
No frothing occurred indicating the absence of saponins.
Test for Tannins
To the aqueous extract of the powdered leaf, few drops of ferric chloride solution 
were added.
Bluish black color was produced, indicating the presence of tannins.
 Gold beater’s skin test
2% hydrochloric acid was added to a small piece of gold beater skin and rinsed 
with distilled water and placed in the solution to be tested for five minutes.  Then washed 
with distilled water and transferred to a 1% ferrous sulphate solution.
 Formation of brown color indicates the presence of tannins.
Test for Proteins and Free Aminoacids
 Millon’s test
The aciduous  alcoholic  extract  of  the  powdered  leaf  was  heated with  Millon’s 
reagent.
The colour was changed to red on heating indicating the presence of proteins.
 Biuret test
To the alcoholic extract of the powdered leaf 1 ml of dilute sodium hydroxide was 
added.  Followed by this one drop of very dilute copper sulphate solution was added. 
Violet color was obtained indicating the presence of proteins.
 Ninhydrin Test
To the extract of the powdered drug, ninhydrin solution was added, and boiled.
Formation of violet color indicating the presence of Aminoacids
Test for Mucilage
To the aqueous extract of the powdered leaf, ruthenium red solution was added. 
No Reddish pink color was produced indicating the absence of Mucilages.
Test for Flavonoids
 Shinoda Test
A little amount of the powdered leaf was heated with alcohol and filtered.  To the 
alcoholic solution a few magnesium turnings and few drops of concentrated hydrochloric 
acid were added, and boiled for 5 minutes.  
Purple color was not obtained indicating the presence of flavonoids.
 Alkaline reagent test
To the  alcoholic  extract  of  the  powdered  leaf,  few  drop  of  sodium  hydroxide 
solution was added.
Yellow color was not formed, indicating the presence of flavonoids
 Zinc Hydrochloride Test 
To the alcoholic extract, mixture of zinc dust and concentrated hydrochloric acid 
was added.
 No formation of red color indicating the presence of flavonoid
Test for Terpenoids
The powdered leaf was shaken with petroleum ether and filtered.  The filtrate was 
evaporated  and  the  residue  was  dissolved  in  small  amount  of  chloroform.   To  the 
chloroform solution tin and thionyl chloride were added.
Pink color was obtained indicating the presence of Terpenoids.
Test for Volatile Oil
About 100 gram of fresh leaves, were taken in a volatile oil estimation apparatus 
(Cocking Middleton apparatus) and subjected to hydro distillation for four hours.
No Volatile oil was obtained indicating the absence of volatile oil.
Test for Fixed Oil
A small amount of the powdered leaf was pressed in between in the filter paper 
and the paper was heated in an oven at 105oC for 10 minutes.
No translucent greasy spot occurred indicating the absence of       fixed oil.
Table - 7
RESPONSE TO THE PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE 



















Liberman Burchard’s test +
V SAPONINS -
VI TANNINS +








XI VOLATILE OIL -
XII FIXED OIL -
The above described tests were also performed on the different extracts of leaf 
powder of P. granatum L. and the results were as follows,
Table – 8
RESPONSE TO THE PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE 











Mayers Reagent - + - - -
Dragendorffs 
reagent
- + - - -
Hagers reagent - + - - -
Wagners reagent - + - - -
CARBOHYDRATES
Molishch’s Test - - - + +
Fehlings Test - - - + +
Benedicts Test - - - + +
GLYCOSIDES
General Test - - - + +
Anthraquinone - - - - -
Cardiac - - - - -
Cyanogenetic - - - - -
Coumarin - - - - -
PHYTOSTEROLS -
Salkowski Test + + - - -
Libermann 
Burchard Test
+ + - - -
SAPONINS - - - - -
TANNINS - - - + +
PROTEINS & FREE 
AMINO ACID
Millons test - - - + +
Biuret test - - - + +
Ninhydrin test - - - + +
GUMS & MUCILAGE - - - - -
FLAVONOIDS
Shinoda test - - + - -
Alkaline Reagent test - - + - -
Zinc hydrochloric 
acid test
- + + - -
TERPENOIDS + + + + -
FIXED OIL - - - - -
       “+” Indicate Positive reaction        “-” Indicate Negative reaction
SECTION – B
TLC & HPLC ANALYSIS FOR VARIOUS EXTRACTS OF LEAVES 
OF P.granatum L.173,177,178
Among the various  methods of  separating  and isolating  plant  constituents the 
“chromatographic Procedure” originated by Tswett is one of the most useful techniques of 
general application. All finely divided solids have the power to adsorb other substances 
are capable of being absorbed some much more readily than others. This phenomenon of 
selective adsorption is the fundamental principle of chromatography.
Principle
When a mixture of  compound is spotted on a TLC plate the compound which 
readily soluble and not strongly absorbed moves up readily along with this solvent. Those 
which are not so soluble, and are more strongly absorbed moves up less readily to the 
separation of the compound.
The advancement of the TLC techniques has provided the organic chemists and 
biochemists  a  tool  which  combines  in  itself  sensitivity  and  rapidity  compared  to  the 
conventional paper chromatographic technique.
Preparation of Extracts
The dried leaf powder of P. granatum L. was extracted in a Buchi rotavapor – R - 
220 extraction apparatus and the extracted solution  was concentrated under  reduced 
pressure.  
The extract was dissolved in Methanol.  Small quantity was taken in a capillary 
tube and it  was spotted on TLC plate 1cm above its bottom end the start  points ere 
equally sized as for as possible. 
Development of chromatogram
The  plates  were  developed  in  a  chromatographic  tank  by  using  a  range  of 
solvents from non-polar to polar as a mobile phase. The plates were allowed to develop 
¾ of the length and then removed. The solvent front was immediately marked and the 
plates were allowed to dry.  Then the plates were examined visually or under UV (or) 
sprayed with different reagents.
The spots were identified and Rf values were determined.
Stationary Phase : TLC Aluminium sheet precoated with           
slicagel 60 F254. (Merck)
Mobile phase used : Chloroform  : Methanol
    8    :         2
Detecting Agent : Methanolic Sulphuric acid
The Rf value was calculated by the following formula.
Rf = Distance travelled by solute front
Distance traveled by  solvent front
Table – 9
RESULTS OF TLC ANALYSIS OF VARIOUS EXTRACTS FROM THE LEAVES OF P. 
granatum L. 
S. 
No Type of Extract Observation Rf value
1. Reference Standard 
(ursolic acid) 
1 spot obtained  pink  0.25
2. Chloroform Extract 3 spots obtained.  pink   
yellow and  green.
0.25, 0.41, 0.53
3. Acetone Extract 3 spots obtained.  pink   
yellow and  green.
0.25, 0.43, 0.55
4. Ethanol Extract 3 spots obtained.  pink   
yellow and  green.
0.25, 0.47, 0.58
The Rf value (0.25) of various extracts coincides with the standard of ursolic acid. 
Hence the pink colour spot may be to ursolic acid. (Plate – 13)
Further  the  amount  of  ursolic  acid  present  in  various  extracts  of  leaves  of 
P.granatum were quantified using HPLC analysis. 
 “HPLC ANALYSIS OF VARIOUS EXTRACTS OF LEAVES OF 
P. granatum L.” 
High performance liquid chromatography179
HPLC was referred to as high pressure liquid chromatography, but nowadays the 
term high performance liquid chromatography is performed.  Since it better describes the 
characteristics  of  the  chromatography  and  avoids  creating  the  impression  that  high 
pressures are an inevitable pre-requisite for high performance.
A typical HPLC unit consist of the following
 A solvent reservoir and mixing system
 A high pressure pump
 A sample inlet pump
 A column (stainless steel)
 A detector and recording unit
Procedure
The appropriate solvents (mobile liquid phase) from the reservoirs are allowed to 
enter the mixing chamber where a homogenous mixture is obtained.  A pump capable of 
maintaining high pressures draws the solvent from the mixing chambers and pushes it 
through the column.
The sample is injected through a port into the high pressure liquid carrier stream 
between the pump and the column.  The separation              takes place on the columns 
which vary from 50 – 100cm in length and            2.3 m.m in i.d.  Typical flow rates are 1-
2ml/min with pressure up to several thousand psi.  The column effluent passes through a 
non-destructive detector where a property such as ultraviolet absorbance, refractive index 
(or) molecular fluorescence is monitored, amplified, and recorded as a typical detector 
response  vs  retention  time  chromatogram.   The  effluent  may  be  either  discarded, 
recycled, or saved for the further studies in a fraction collector which is synchronized with 
the detector.
Practical Procedure
There are two methods which are generally used.
First method makes use of micro syringe designed to with stand high pressure. 
The sample is injected through a septum in an injection port,  either directly on to the 
column packing (or) on to a small plug of inert material immediately above the column 
packing.  This can be done while the system is under pressure, or the pump may be 
turned off before injection and when the pressure has dropped to near atmospheric, the 
injection is made and the pump switched on again.  This is termed a stop flow injection.
In the second method, the sample is introduced by use of a loop injector.  This 
consists of a metal loop of small volume which can be filled with the sample.  By means 
of an appropriate valve, the eluant from the pump is channeled through the loop, the 
outlet of which leads directly on to the column.  The sample is thus flushed on to the 
column by the eluant, without interruption of solvent flow to the column.
Repeated application of highly impure samples such as sera, urine which have 
preferably  been deproteinated  may eventually  cause the column to  lose its  resolving 
power.
To prevent this occurrence a guard column is installed between the injection and 
the analytical column.
HPLC Analysis of various extracts of P. granatum L.  leaves (Fig. 5,6) 
Instrument : Shimadzu BM – 101
Liquid Chromatogram : 10 ATVP Shimadzu liquid chromatography
Column Used : C-18 ODS Column
Column No : SLL / P / HPLC / 68
Detector : SPD – 10 AVP Shimadzu UV – Vis detector
Wave length : 210 nm
Mobile Phase : ACN : Methanol
Flow rate : 0.5ml/1min
Injection volume : 20 µl
Standard (Ursolic acid) : 30.40mg / 100ml
Ursolic acid Potency : 84.84 
Results
By comparing  the  peaks  obtained  from various  (chloroform,  acetone,  ethanol) 
extracts of P.granatum with the peak area of reference standard ursolic acid, it was found 
that the various extracts contain ursolic acid and the HPLC data were as follows (Fig – 4 
– 8).  
Table – 10
RESULTS OF HPLC ANALYSIS FO VARIOUS EXTRACTS FROM THE LEAVES OF P.granatum
S.NO Parameters











1. Weight (in mg/100ml) 30.40 421 283.60 243.50 401.20
2. Peak Area – 1 3576647 11744297 129228 48457
Not 
detected
3. Peak Area –  2 3530697 11942826 125300 52757
4. Peak Area –  3 3593624 - - -
5. Average 3566989.33 11843561.50 127264 50607
6. Standard Deviation 32556.18 140381.20 2777.52 3040.56
7. Assay (%w/w) As such 20.34 0.32 0.1503
Calculation :



















ACUTE TOXICOLOGICAL STUDY USING
BRINE SHRIMP LETHALITY ASSAY
The importance  of  medicinal  plants  and traditional  health  systems solving  the 
health care problems of the world is gaining increasing attention. Most of the developing 
countries have adopted traditional medical practice as an integral part of their culture.
In  order  to  study  the  toxicity  of  these  medicinal  plants  we  performed  Brine 
Shrimp Lethality Bioassay which based on the ability to kill  laboratory cultured brine 
shrimp (Artemia nauplii). The brine shrimp assay was proposed by Michael148 et al latter 
developed by Vanhaecke et al149 Sleet and Brendel et al150. The assay is a useful tool for 
preliminary assessment of toxicity and it has been used for the detection of fungal toxins, 
plant extract toxicity, heavy metals, pesticides and cytotoxicity testing of dental materials.
The method is  attractive because it  is  very simple,  inexpensive  and low toxin 
amounts are sufficient to perform the test in the micro well scale.
Production of Artemia Strain
Artemia  is  a  non-selective  filter  feeder  of  organic  detritus,  micro  algae  and 
bacteria. Artemia are naturally found in saltpans, hypersaline lakes and coastal lagoons 
as well as in the man made Saltpans. When the cysts are inoculated in seawater for 24 
hrs, the free – swimming nauplii are hatched out.
Cytotoxicity Bioassay151 
Ten  nauplii  were  drawn  through  a  glass  capillary  and  placed  in  each  vial 
containing 4.5 ml of brine solution. In each experiment, 0.5 ml of the extract was added to 
4.5 ml of brine solution and maintained at room temperature for 24 hrs under the light and 
surviving larvae were counted. Experiments were conducted along with control (vehicle 
treated),  different concentrations of the chloroform extract (100-7500 ppm) in a set of 
three tubes per dose.
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Lethality Concentration Determination
The percentage lethality was determined by comparing the mean surviving larval 
of the test and control tubes. LC50 value was obtained from the best – fit  line, plotted 
concentration verses percentage lethality. Podophyllotoxin was used as a positive control 
in the bio assay (Fig – 9).
Statistical Analysis
The percentage lethality was calculated from the mean survival larvae of extract 
treated tubes and control. LC50 values were obtained by best-fit line method.
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Table - 11
EFFECT OF VARIOUS CONCENTRATIONS OF CHLOROFORM                EXTRACT 
FROM LEAVES OF P. granatum L.
ON ARTEMIA NAUPLII
















































10 - - -
10 - - -




In Alzheimer’s Disease (AD), the brain is characterized by selective neuronal loss, 
neurofibrillary  tangles,  and extracellular  deposits  of  insoluble  amyloid  that  form senile 
plaques.  The nucleus basalis of Meynert, the diagonal band of Broca, and the medial 
setum  of  the  basal  forebrain  provide  cholinergic  projection  to  the  cerebral  cortex, 
hippocampus and amygdala.  The cholinergic system is responsible for the storage and 
retrieval of items in memory.  Its degradation correlates well with the severity of cognitive 
and memory impairment.  Moreover, the severity of dementia is closely correlated with 
both synapse and neuronal loss in the neocortex and hippocampus (Plate 16 – 18).
As the cognitive dysfunction and other features of AD are mediated by the loss of 
function at cholinergic synapses in the neocortex and hippocampus, agents replacing the 
lost cholinergic function should be useful in the management of this disease.
One strategy for ameliorating symptoms of AD is the restitution of a near normal 
acetylcholine  concentration  in  the  synaptic  cleft  to  enhance  cholinergic 
neurotransmission. Acetylcholinesterase inhibitors reduced the hydrolysis of acetylcholine 
to  boost  the  endogenous  level  of  acetylcholine  in  the  brain  and  thereby  to  boost 
cholinergic neurotransmission. This resulted in the improvement of cognitive function in 
mild to moderate AD. Some patients, however, demonstrated a dramatic improvement in 
cognitive scores that was readily observable in their daily functions
Ursolic  acid  (UA),  a  pentacyclic  triterpene  acid,  has  been  isolated  from many 
kinds  of  medicinal  plants,  such  as  Eriobotrya  japonica,  Rosemarinus  officinalis,  
Glechoma hederaceae. Ursolic acid has been reported ro produce anti-tumor activities, 
including the inhibition of skin tumorigenisis and inhibition of tumor promotion . It also 
induced tumor cell  differentiation by the regulation of the expression of differentiation-
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specific genes in mouse F9 teratocarcinoma cells. In addition, ursolic acid was shown to 
possess an anti-angiogenic effect on the chick chorioallantoic membrane, and an anti 
invasive activity on HT1080 human fibrosarcoma cells.  It  was proved that ursolic acid 
from Origanum majorana appeared to be a potent AChE inhibitor in Azhimer’s disease17.
In our study it was found that chloroform, acetone, ethanol extracts of defatted, 
shade dried, powdered leaves of  P.granatum  contains ursolic acid and the percentage 
were determined by HPLC.
The previous report of ursolic acid as potent AChE inhibitor and its presence in 
the leaves of  P. granatum which is available freely at lower cost  and not used for any 
other purpose after fruit harvest has inspired us to carryout AChE inhibitor activity.
METHOD
Ellman Esterase Assay procedure was performed.The method aims to determine 
the  rate  of  hydrolysis  of  acetylthiocholine  (ATCh)  by  acetylcholinesterase(AChE)  in 
tissues taken from laboratory rat17,62,152,153,154.
PRINCIPLE
This assay is a spectrophotometric method, which involves two linked reactions to 
produce  a  coloured  compound.  The  production  of  the  compound  is  monitored  by 
measuring the absorbance of light by the reaction mixture over time. ATCh is hydrolyzed 
enzymatically  to  give  acetate  and thiocholine.  Thiocholine  reacts with  5,51-dithiobis-2-
nitrobenzoic  acid(DTNB)  producing  the  yellow  coloured  5  thiobis-2-nitrobenzoic 




Apparatus/Instrument used Name of the Company
Microplate Reader : Fluostar optima, BMG
Sonicator : Analytical lab suppliers
Vortex mixer : Serwell instruments Ltd
pH meter : Thermo
Analytical balance : Sartorius
Micro pipette : Thermo
2. MATERIALS
Apparatus/Instrument used Name of the Company
Eppendorf vials : Tarson
Pipette tips  2-200 μl : Tarson
Pipette tips  200- 1000 μl : Tarson
Beakers : Borosil
96 well micro plate(white) : Becton Dickinson
Distilled water : Spectrum
Sptula : -
3. REAGENTS
Reagent used Name of the Company
Sodium phosphate(monobasic) : Merck
Sodium phosphate(Dibasic) : Merck
Acetylthiocholine iodide(ATCI) : Sigma
Acetylcholinesterase(AChE) : Rat brain tissue
5,51-dithiobis-2-nitrobenzoic acid(DTNB) : SRL
Tacrine : Sigma
4. Reagent preparation
 Phosphate buffer (0.1 M, pH 8)
2.69  grams of  Dibasic  sodium phosphate,  0.146  grams of  monobasic  sodium 
phosphate was added in 100 ml of double distilled water(DD water) and pH was adjusted 
to pH 8 and  the volume was made upto 200 ml by adding DD water.
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 Enzyme 
100 mg of rat brain tissue was homogenized with 5 ml of  phosphate buffer ; it was 
then aliquoted into vials under sterile conditions and stored at -80o
 Substrate (ATCI)
Molecular weight of substrate = 289.18 g.
 Ellman reagent (DTNB)
Molecular weight of DTNB =  396.35 g.
 Control (Tacrine)
Molecular weight of Tacrine = 234.73 g.
 Sample 
Stock solution  =  500 mg of  samples  were  weighed  and  dissolved  in  1000  μl 
DMSO (Dimethyl sulphoxide)
PROCEDURE
Rat striata are homogenized in 10 volumes of 0.1 M phosphate buffer(pH 8.0). 
Five minutes after the addition of 400 μl of homogenate,         30 μl of test compound 
solution  at  various  concentrations,  and  100  μl  of  DTNB(10mM)  to  2.45  ml  of  0.1  M 
phosphate buffer(pH 8.0) are added and AChE activity is determined at 250  C over 1 
minute  in  a  photocell  after  the  addition  of  20  μl  of  acetylthiocholine  iodide(ATCI)  as 
substrate.
A substrate blank(i.e., no tissue, only substrate and buffer and DTNB) should be 
run  with  each  group  of  assays;  this  measures  nonenzymatic  substrate  hydrolysis.  A 
tissue blank(i.e., only tissue, buffer and DTNB but no substrate) should be run for each 
tissue to determine the degree of binding of DTNB to sulfhydryls in the tissue sample. If  
this is minimal after the preincubation period, then the tissue blank will not be needed on 
a regular basis for that tissue.
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The activity was calculated by using the formula
SECTION – A
STANDARDIZATION AND VALIDATION OF ELLMAN METHOD
1. Standardization of assay using different concentrations of Enzyme
1. Into the 96 well (white) microtitre plate, 150μl (0.1M Phosphate) buffer in enzyme 
blank (EB), substrate blank (SB) and 140-50μl buffer in respective activity wells.
2. 50μl enzyme was added in enzyme blank, except in substrate blank well.
3. 10-100μl of enzyme was added in respective activity wells.
4. 50μl of DTNB was added in all wells.
5. 50μl of ATCI was added in all wells except enzyme blank.
6. Absorbance was read at the intervals of 10 minutes at 405 nm in microplate 
reader in duplicate.
Table - 12
STANDARDIZATION OF ENZYME CONCENTRATION
Contents 
(µ l) EB SB A B C D E F G H I J




















Velocity (V)  = 
Change in Absorbance / min
molar extinction coefficient 13600
85
Table -13
EFFECT OF DIFFERENT VOLUME OF ENNZYME IN AChE ACTIVITY (Fig – 10)
S.No. Volume of Enzyme Absorbance Activity
1. 10 0.04585 3.37132
2. 20 0.077 5.66176
3. 30 0.1088 8
4. 40 0.13465 9.90074
5. 50 0.14955 10.9963
6. 60 0.15215 11.1875
7. 70 0.1554 11.4265
8. 80 0.13485 9.91544
9. 90 0.12475 9.17279
10. 100 0.12755 9.37868
Result
The volume of enzyme at 40µl, 50µl were found to be ideal concentration at which 
the enzyme activity will be linear.  Above the enzyme volume 50µl showed saturation so 
we performed the same experiment to confirm the suitable concentration from 40μl, 50μl.
Finally,  the enzyme at  50  µl  volume was  selected for  the assay at  which the 
enzyme activity will be linear. 
2.  Standardization  of  assay  using  different  concentration  of  substrate  
1. Into the 96 well microtitre plate, 150  µl buffer in enzyme blank, substrate blank 
and 100 µl buffer in respective activity wells.
2. 50µl enzyme was added in all wells except in substrate blank
3. 50µl of DTNB was added in all wells.
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4. 50µl  of  ATCI  different  concentrations  from  4mM  –  0.125mM  was  added  in 
respective activity wells (A to Q).
5. Absorbance  was  read  at  the  intervals  of  10  minutes  at  405nm  in  microplate 
reader.
Table -14
STANDARDIZATION OF SUBSTRATE CONCENTRATION
Contents 
(µ l) EB SB A B C D E F G H I J K L M N O P Q
Buffer 150 150 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Enzyme 50 - 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
DTNB 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
ATCI - 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
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Table - 15
EFFECT OF VARIOUS CONCENTRATON OF
 SUBSTRATE IN AChE ACTIVITY (Fig – 11)
S.NO. Concentration mM [S] Absorbance. V Activity 1/[S] 1/V
1. 4 0.092155 6.776103 - -
2. 3.75 0.1154 8.485294 - -
3. 3.5 0.1073 7.889706 0.285714 9.319664
4. 3.25 0.1047 7.698529 0.307692 9.551098
5. 3 0.10395 7.643382 0.333333 9.62001
6. 2.75 0.10825 7.959559 0.363636 9.237875
7. 2.5 0.1082 7.955882 0.4 9.242144
8. 2.25 0.10575 7.775735 0.444444 9.456265
9. 2 0.10935 8.040441 0.5 9.144947
10. 1.75 0.1121 8.242647 0.571429 8.920607
11. 1.5 0.11725 8.621324 0.666667 8.528785
12. 1.25 0.1153 8.477941 0.8 8.673027
13. 1 0.1083 7.963235 1 9.23361
14. 0.75 0.11205 8.238971 1.333333 8.924587
15. 0.5 0.1056 7.764706 2 9.469697
16. 0.25 0.08975 6.599265 4 11.14206
17. 0.125 0.0434 3.191176 8 23.04147
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Determination of Km value
1. Michalis - Menten graph can be plotted by taking [S] in mM concentration on X - axis 
and V in mM / min on Y - axis.
Michalis - Menten equation :
V = 
V max [ S ]
K m[ S ]
Where, V = Initial rate of production of product
  Vmax – Maximum initial rate of production of product
  [S] – substrate concentration
  Km – Michalis - Menten rate constant (The substrate concentration that produces 
half the maximum velocity)
Lineweaver Burk plot is sensitive to data error and is strongly biased in fitting data 
in  low  concentration  range.  The  reciprocal  of  Michalis  -  Menten  equation  gives 






V max [S ]
 1
V max
Y = mx + c
Where, m = slope (Km/Vmax) 
   C = Intercept (1/Vmax)
From the graph we got 
   Y = 1.6114 x + 7.977
Vmax = 1/c = 0.1253




From Km value, the substrate at 0.5 mM was found to be the ideal concentration at 
which the enzyme activity will be linear.
3.  Standardization  of  assay  using  different  concentrations  of  Ellman  
     reagent (DTNB)
1. Into the 96 well microtitre plate, 150 µl buffer in enzyme blanks, substrate blank 
and 100 µl buffer in respective activity wells.
2. 50µl enzyme was added in all wells except in substrate blank.
3. 50 µl of DTNB different concentrations from 5.28 mM – 0.0412 mM was added in 
respective activity wells (A to H).
4. 50 µl of 0.5mM ATCI was added in all wells except enzyme blank well.
5. Absorbance  was  read  at  the  intervals  of  10  minutes  at  405nm  in  microplate 
reader.
Table – 16
STANDARDIZATION OF ELLMAN REAGENT 
CONTENTS 
(µ l) EB SB A B C D E F G H
Buffer 150 150 100 100 100 100 100 100 100 100
Enzyme 50 - 50 50 50 50 50 50 50 50
DTNB 50 50 50 50 50 50 50 50 50 50
ATCI - 50 50 50 50 50 50 50 50 50
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Table - 17
EFFECT OF DIFFERENT CONCENTRATON OF
ELLMAN REAGENT IN AChE ACTIVITY (Fig – 13)


























From this experiment the ideal concentration of DTNB was found to be 0.33 mM.
4. Estimation of pH Maxima
1. Into the 96 well microtitre plate, 150  µl buffer in enzyme blank, substrate blank 
and 100 µl buffer of different pH 7 – 9 was added in respective activity wells (A to 
E)
2. 50 µl enzyme was added in all wells except in substrate blank.
3. 50µl of 0.33mM DTNB was added in all wells.
4. 50µl of 0.5mM ATCI was added in all wells except enzyme blank.




ESTIMATION OF pH MAXIMA
Contents 
(µ l) EB SB
ACTIVITY
A B C D E
Buffer 150 150 100 100 100 100 100
Enzyme 50 - 50 50 50 50 50
DTNB 50 50 50 50 50 50 50
ATCI - 50 50 50 50 50 50
Table - 19
EFFECT OF pH IN AChE ACTIVITY (Fig – 14)







It was proved from the experiment that the buffer in pH 8, showed good enzyme 
activity, so we have selected pH 8 for the assay.
5. Estimation of Temperature Maxima
1. Into the 96 well microtitre plate, 150  µl buffer in enzyme blank, substrate blank 
and 100 µl buffer of pH 8 was added in respective activity wells.
2. 50µl enzyme was added in all wells except in substrate blank.
3. 50µl of 0.33 mM DTNB was added in all wells.
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4. 50µl of 0.5mM ATCI was added in all wells except enzyme blank.
5. Absorbance was read at the intervals of 10 minutes at 405nm in microplate reader 
at different temperature from 28 – 420C.
Table - 20
ESTIMATION OF TEMPERATURE MAXIMA
Contents 
(µ l) EB SB ACTIVITY
A B C D E F G
Buffer 150 150 100 100 100 100 100 100 100
Enzyme 50 - 50 50 50 50 50 50 50
DTNB 50 50 50 50 50 50 50 50 50
ATCI - 50 50 50 50 50 50 50 50
Table - 21
EFFECT OF TEMPERATURE IN AChE ACTIVITY (Fig – 15)









It  was proved from the experiment that the temperature at 370C showed good 
enzyme activity, so we selected the temperature at 370C for the assay.
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Section B
SCREENING OF SAMPLES FOR AChE INHIBITORY ACTIVITY
1. Estimation of AChE inhibitors Tacrine, Ursolic acid and extracts
1. Into the 96 well microtitre plate, 150µl  buffer in enzyme blank, substrate blank, 
100 µl buffer in activity well and 50µl buffer of pH 8 was added in activity inhibition 
well.
2. 50µ l enzyme was added in all wells except in substrate blank.
3. 50µl of 0.33mM DTNB was added in all wells.
4. 50µl of reference standard ursolic acid, tacrine, were added in activity inhibition 
well.
5. 50µl of 0.5mM ATCI was added in all wells except enzyme blank.
6. Absorbance was read at the intervals of 10 minutes at 405nm in microplate reader 
at 37oC.
Table - 22




EB SB Activity Inhibition
Buffer 150 150 100 50
Enzyme 50 - 50 50
DTNB 50 50 50 50
Inhibitor - - - 50
ATCI - 50 50 50
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Table - 23
EFFECT OF DIFFERENT CONCENTRATION OF URSOLIC 
ACID IN AChE INHIBITION (Fig – 16)
S.No. Concentration (µ M) % Inhibition % Inhibition
1. 500 96.533330 95.338870
2. 250 86.285710 86.700770
3. 125 67.174610 71.483380
4. 62.5 45.968250 50.831200
5. 31.125 28.761910 36.636830
Table - 24
EFFECT OF DIFFERENT CONCENTRATION OF TACRINE 
IN AChE INHIBITION (Fig – 17)
S.No. Concentration (nM) % Inhibition % Inhibition
1. 1600.0 89.926620 92.524590
2. 800.0 85.523680 88.983600
3. 400.0 71.914610 79.868850
4. 200.0 65.510340 65.311480
5. 100.0 48.298870 49.114750
6. 50.0 29.686460 32.721310
7. 25.0 18.212140 19.213120
8. 12.5 7.938626 7.344262
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Table - 25
SIGMOIDAL DOSE – RESPONSE (VARIABLE SLOPE)
Best fit values Ursolic Acid Tacrine
Bottom 0.0 0.0
Top 100.0 100.0




Log EC50 0.02194 0.01580
Hill slope 0.08550 0.03376
95% Confidence Intervals
Log EC50 1.736 to 1.837 2.015 to 2.082
Hill slope 1.046 to 1.441 0.9082 to 1.053
EC50 54.46 to 68.75 103.4 to 120.9
Goodness of Fit
Degrees of Freedom 8 14
R2 0.9820 0.9940
2. SCREENING OF AChE INHIBITORY ACTIVITY FOR VARIOUS EXTRACTS OF 
LEAF P. granatum
Preparation of the test solution :
Test solution for the evaluation of AChE inhibitory activity were prepared by 
dissolving the dried extracts in DMSO (Dimethyl Sulphoxide).




EFFECT OF DIFFERENT CONCENTRATION OF VARIOUS 
EXTRACTS IN AChE INHIBITION (Fig – 18, 19, 20)
S.NO. Concentration (mg/ml)
% Inhibition of Extracts
Chloroform Acetone Ethanol Aqueous
1. 4 94 76 90 Nil
2. 2 51 48 54 Nil
3. 1 26 27 29 Nil
4. 0.5 12 11 14 Nil
5. 0.25 1.3 6.4 2 Nil
Table - 27




Bottom 0.0 0.0 0.0
Top 100.0 100.0 100.0
Log EC50 0.2563 0.3329 0.2507
EC50 1.804 2.152 1.781
Std. Error
Log EC50 0.1469 0.06484 0.1121
95% Confidence Intervals






EC50 0.7057 to 
4.613 1.466 to 3.160 0.9172 to 3.458
Goodness of Fit
Degrees of Freedom 4 5 5
R2 0.8307 0.9451 0.8871
The data were represented by sigmoidal dose response graph               (Fig. 16 –  
20).
Result
The  percentage  inhibition  and  IC50 data  for  tacrine,  ursolic  acid,  and  various 
extracts were presented in Table No 27.
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Table – 28
COMPARISON OF IC50 VALUE AND PERCENTAGE INHIBITION OF STANDARD AND 
EXTRACTS IN AChE INHIBITION  
S.NO. Standard and Extracts Concentration % Inhibition IC50
1. Tacrine 1600 nM 93% 111.8nM
2. Ursolic acid 500 µM 95% 61.19µM
3. Chloroform extract 4 mg / ml 94% 1.8mM
4. Acetone extract 4 mg/ml 76% 2.1mM
5. Ethanol extract 4 mg/ml 90% 1.8mM
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RESULTS AND DISCUSSION
This  dissertation  covers  the  investigations  on  pharmacognostic, 
phytochemicals  and  invitro  AChE  inhibition  of  the  various  extracts  of 
defatted,  shade  dried,  powdered  leaves  of  P.granatum,  var.:  Ganesh, 
Family:Punicaceae.
In Chapter – 1 : Introduction, We discussed medicinal plants global 
view → WHO views on medicinal plants – Status of India → Contribution by 
Tamilnadu  → Modern medicine demerits  → Natural  products  for  modern 
medicine  → Priorities in medicinal plant research  → phytonutrients – The 
natural drugs of the future → Degenerative diseases → Alzheimer’s disease 
→ Symptoms of AD → Characteristics of AD → Current treatment → List of 
medicinal plants having AChE inhibition → Ursolic acid and AChE inhibition 
→ reason for selection of plant P.granatum.  
In Chapter 2 :  Review of Literature, the various literature available 
were categorized under ethnomedical, pharmacognostical, phytochemical, 
pharmacological  and  biological  screening  of  entire  plant,  aerial  parts, 
flower,  fruit,  fruit  juice,  peel,  rind,  pericarp,  leaves,  bark  root  and  acute 
toxicological study methods and AChE inhibitory activity screening methods 
were reviewed.
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In Chapter  3 :  Aim and Objective were set  to obtain  a potential 
benefit  to  treat  Alzheimer’s  disease by FDA approved  method of  AChE 
inhibition by considering the following reasons.
 A  new  effective  plant  based,  easily  available  AChE  inhibitor  to 
provide a new dimension in the therapy of Alzheimer’s disease.
 Hence to provide significant contribution to the chemotherapy of this 
disease  by  natural  product  derived  compound  in  future  in  an 
affordable way to reduce the incidence of Alzheimer’s disease.
Chapter : 4 Pharmacognositc studies
Section : A
Taxonomy,  synonym,  vernacular  name,  subspecies,  geographical 
distribution,  habit  &  habitat,  subspecies  which  includes  morphological 
description  of  all  parts,  of  the  plant  and  further  climate,  soil  condition, 
manuring of the cultivation varieties of P.granatum were discussed in detail 
to identify the plant with support of photographs, and line drawings as an 
establishment of authenticity (Plate – 1 to 7, Fig.: 1)
Morphology of the Leaf
Size : 2 - 8 cm




Base : Narrowed into a very short petiole
Odour : Agreeable Odour
Taste : Tasteless
Section  -  B  deals  with  the  microscopic  studies  of  leaves  of 
P.granatum to ascertain the arrangement of tissues (Plate No - 8 - 12). 
The  T.S.  of  leaf  through  midrib  of  mature,  young  leaf  and  the  powder 
analysis showed the following features (Fig - 3).
The  leaf  has  thick  semicellular  midrib  and  thin  lamina.   In  cross 
sectional view, the lamina exhibits distinct dorsiventral symmetry.
Midrib
Has wide dorsal concavity and thick hemispherical abaxial part.
Epidermal Cells
Are either rectangular or polygonal with slightly wavy anticlinal walls 
and cells are thin cuticular striations.
Abaxial epidermis
 Has stomata anomocytic (Ranunonculaeous),  no distinct subsidiary 
cells are seen.  Walls are undulate, amoeboid out lines and guards cells are 
oblong, elliptic.
Vascular bundle
Simple, wide and bowel shaped with adaxial cavity.
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Xylem
Dense parallel lines, narrow thick walled angular in out line.
Pholem
Thin, present in abaxial layer.
Lamina
80 µm thick and has thick adaxial epidermis which consists of wide 
rectangular cells 20 µm in thick.
Mesophyll
Single  layer  adaxial  palisade  cells,  20-30  µm  in  height,  spongy 
parenchyma about five layers of large circular closed arranged cells.
Idioplast
Specially modified, dilated cavities bearing calcium oxalate crystals are frequently 
seen. Crystals may be prismatic (20-40 µm thick) or druses (30µm thick).
Venation Pattern
Secondary and tertiary veins are uniformly thin and wavy.  Some vein islets are 
distinct.  The vein terminations are short, straight ends or simple.
Petiole 
  The proximal end of petiole side semi circular with wide abaxial, and concavity two 
short and thick lateral wings, 1.2mm in vertical axis and 1.4mm in horizontal axis.
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Distal end
The distal end of petiole has deep ‘V’ shape adaxial groove, long and prominent 
wings, which is 1mm vertical, 1.25mm horizontal, epidermal layer of small squarish cells. 
Phloem prominent in the lower part of the xylem, vascular strand is 600µm wide, 250µm 
thick.
Section  -  C deals  with  the  quantitative  microscopy  in  terms  of 
microscopical and physical parameters and the results were tabulated from 
table No. 1 to 6.
The following evaluations were carried out for leaf
S.No. Parameters Minimum Average Maximum
1. Vein islet Number 24 31 37
2. Vein termination number 21 24 28
3. Stomatal  Number  (lower 
epidermis)
187 205 217
4. Stomatal  Index  (lower 
epidermis)
9.42 10.84 12.24
5. Total Ash (% W/W) 10.78 11.10 11.49
6. Acid insoluble ash 
(% W/W)
1.46 1.51 1.56
7. Water soluble ash 
(% W/W)
2.52 2.8 3.02













Chapter – 5 – Preliminary Phytochemical Studies 
Section  –  A deals  with  the  preliminary  qualitative  phytochemical 
examination  of  the  powdered  leaves  of  P.granatum and  results  were 
tabulated from Table No. : 7. 
Part Constituents Present Constituents Absent
Leaf Powder Alkaloids, carbohydrates, 
proteins, phytosterol tannins, 
flavonoids, terpenoids, 
glycosides. 
Volatile  Oil,  Fixed  oil, 
mucillage
The preliminary qualitative phytochemical examination of the extract 
obtained by individual extraction of powdered drug using various solvents of 
increasing polarity  were  carried out  and the results  were tabulated from 
Table No. 8. 
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Schematic  representation  of  various  constituents  present  in  the 






























Section – B deals with the preparation of the Chloroform, acetone, 
ethanol, and aqueous extracts to determine the percentage of ursolic acid 
present and to screen them for AChE inhibitory activity depending upon the 
presence of ursolic acid.
The presence of ursolic acid in the chloroform, acetone, ethanol and 
aqueous extracts were identified by Co-TLC and the Rf value of ursolic acid 
was found to be 0.25 (Table – 9, Plate - 13).
The estimation  of  ursolic  acid  content  in  the  chloroform,  acetone, 
ethanol  and  aqueous  extracts  were  done  by  using  HPLC  analysis 
(Table – 10, Fig – 4 - 8)  




1. Chloroform Black Powder 20.34
2. Acetone Dark Brown paste 0.32
3. Ethanol Greenish Brown paste 0.15
4. Water Brown Lumps Nil
In Chapter - 6 The Acute toxicological study was carried out for the 
chloroform  extract  of  P.grantum by   Brine  Shrimp  Lethality  Bioassay 
(Plate – 14,15).
This method is attractive because it is very simple, inexpensive and 
low concentration is sufficient to perform the test in micro well scale.
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The  methodology  for  cytotoxicity  bioassay  was  discussed  in  this 
chapter. The percentage lethality was determined by comparing the mean 
surviving larvae of the test and control tubes.
The mortality of larvae was calculated after 24 hrs, by using Abbot’s 
formula,  it  was  corrected  and tabulated  in  Table  11.  The percentage of 
mortality recorded in the chloroform extract  were  23.3,  23.3,  33.3,  43.3, 
43.3,  50,  63.3,  66.6  at  100,  250,  500,  1000,  2500,  5000,  6000  and 
7500 ppm respectively (Fig – 9). 
The LC50 values were obtained from the regression plot by plotting 
concentration verses % lethality.  Podophyllotoxin was used as a positive 
control – 100% mortality at 3 ppm.
The LC50 values suggested that chloroform extract is non toxic, 
The LC50 values for chloroform extract by BSLB was 2100 ppm and it 
need  further  evaluation  in  animal  model  by  acute  and  chronic 
toxicological study.
Chapter – 7 
Section : A deals with description about the Alzheimer’s disease, its 
manifestation,  current  therapy  and  its  limitations,  need  for  the  research 
were dealt in the introduction (Plate – 16, 17, 18).
 The AChE assay was performed according to the colorimetric method 
of Ellman et al using ATCI as a substrate153.
 Standardization & Validation of AChE inhibitory activity.
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 Initially a test trial was conducted to standardize various parameters 
like  pH,  temperature  and  the  suitable  concentrations  for  AChE 
enzyme, substrate,  reagent  (DTNB). The results  were tabulated in 
Table 12 - 20 and represented graphically.   From the result it was 
clear that the pH maxima = 8, and temperature maxima = 370C. The 
optimum  concentrations  of  AChE  enzyme,  substrate  and  reagent 
were  found  to  be  50µl,  0.5mM  and  0.33  mM  respectively 
(Fig 10– 15).
Section  :  B deals  with  the  Screening  of  AChE  inhibitory  activity  of 
various extracts of leaves of P.granatum:
From  the  results  of  HPLC  the  percentage  of  ursolic  acid  in  the 
various  extracts  prepared  successively  using  defatted,  shade  dried, 
powdered  leaves  of  p.granatum for  chloroform,  acetone,  ethanol,  were 
20.34, 0.32, 0.15 respectively.  Since all these extracts containing ursolic 
acid,  we  planned  to  carry  out  AChE inhibitory  activity  of  these  extracts 
along with aqueous, prepared from the above marc, since it is economic, if 
it is effective.
Chloroform,  acetone,  ethanol,  aqueous  extracts  obtained  from 
defatted,  shade  dried,  powdered  leaves  of  P.granatum by  successive 
extraction were screened by using 0.25, 0.5, 1, 2, 4 mg/ml
The percentage inhibition for reference standard and various extracts 
were presented in (Table No- 22,23,25).
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EFFECT OF DIFFERENT CONCENTRATION OF URSOLIC 
ACID IN AChE INHIBITION
S.No. Concentration (µ M) % Inhibition % Inhibition
1. 500 96.533330 95.338870
2. 250 86.285710 86.700770
3. 125 67.174610 71.483380
4. 62.5 45.968250 50.831200
5. 31.125 28.761910 36.636830
EFFECT OF DIFFERENT CONCENTRATION OF TACRINE 
IN AChE INHIBITION
S.No. Concentration (nM) % Inhibition % Inhibition
1. 1600.0 89.926620 92.524590
2. 800.0 85.523680 88.983600
3. 400.0 71.914610 79.868850
4. 200.0 65.510340 65.311480
5. 100.0 48.298870 49.114750
6. 50.0 29.686460 32.721310
7. 25.0 18.212140 19.213120
8. 12.5 7.938626 7.344262
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EFFECT OF DIFFERENT CONCENTRATION OF VARIOUS EXTRACTS 
IN AChE INHIBITION 
S.NO. Concentration (mg/ml)
% Inhibition of Extracts
Chloroform Acetone Ethanol Aqueous
1. 4 94 76 90 Nil
2. 2 51 48 54 Nil
3. 1 26 27 29 Nil
4. 0.5 12 11 14 Nil
5. 0.25 1.3 6.4 2 Nil
The  data  were  represented  by  sigmoidal  dose  response  graph. 
(Figure 16 - 20). 
COMPARISON OF IC50 VALUE AND PERCENTAGE INHIBITION OF STANDARD AND 
EXTRACTS IN AChE INHIBITION  
S.No. Standard and Extracts Concentration % Inhibition IC50
1. Tacrine 1600 Nm 93% 111.8nM
2. Ursolic acid 500 µM 95% 61.19µM
3. Chloroform extract 4 mg / ml 94% 1.8mM
4. Acetone extract 4 mg/ml 76% 2.1mM
5. Ethanol extract 4 mg/ml 90% 1.8mM
From the study the percentage inhibition and IC50 value for chloroform 
&  ethanol  extracts  were  found  there  94,  1.8  mM  and  90,  1.8mM 
respectively.   The % inhibition and IC50 value for chloroform, ethanol 
extracts  were  promising  at  4  mg/ml  concentration  level  in  a  dose 
dependent manner.
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The result shows that the Chloroform and ethanol extracts were 
active at 4mg/ml concentration but less comparable to the standard 
drugs tacrine and the triterpenoid ursolic acid which are active at 1600 
nM and 500µ M concentration respectively.
It was also observed that acetone extract was comparable with 
that of chloroform, ethanol extract in the same concentration level in 
dose dependent manner (76% inhibition, IC50 2.1mM).
But aqueous extract did not inhibit the AChE enzyme activity in 
the same concentration level.  All other extracts showed greater than 
75% inhibition at 4 mg/ml concentration.  In the light of the present 
results  we  can  expect  the  leaves  of  P.grantum to  be  helpful  in 
neurodegenerative  disorders  like  AD  by  reducing  the  enzymatic 
degradation  of  acetylcholine  which  is  only  currently  approved 
treatment of AD by USFDA and EMEA.
The component responsible for AChE inhibition activity in the 
chloroform extract may be due to the higher concentration of ursolic 
acid (20.34%).  Since it was already reported that ursolic acid act as 
AChE inhibitor in a dose dependent and competitive / non-competitive 
manner with a Ki value of 6 pM representing the affinity of the enzyme 
and inhibitor.
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The alcohol, acetone activity in these investigation may act on 
different  mechanism though it  contain  low concentration of  ursolic 
acid 0.32%, 0.15% respectively.
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CONCLUSION
This  dissertation  covers  the  pharmacognostic  parameters  of  the 
leaves  of  Punica  granatum,  Var.  Ganesh belonging  to  the  family:  
Punicaceae,  such  as  macroscopical,  microscopical  including  powder 
analysis and physical standards like ash values, extractive values, etc have 
been studied and presented.
 Microscopical  studies  reveals  the  presence  of  calcium  oxalate 
prismatic  crystals,  druses  in  the  mesophyll  region  and  uniform 
parallel striations in the upper epidermis along with usual leaf tissues.
 The  preliminary  phytochemical  studies  reveals  the  presence  of 
alkaloid,  carbohydrate,  glycoside,  phytosterol,  tannins,  proteins, 
flavonoids, terpenoids in leaf powder.
 TLC of  the chloroform,  acetone  and ethanol  extracts  of  leaves  of 
P.granatum shows the presence of ursolic acid.
 The  percentage  of  ursolic  acid  in  chloroform,  acetone,  ethanol 
extracts were determined by HPLC as 20.34, 0.32, 0.15 respectively.
 The commercial exploitation of ursolic acid is recommended.
Acute toxicological study In the present study it was confirmed that 
the chloroform extract was nontoxic and the LC50 value was 2100 ppm and 
it need further evaluation in animal model by acute & chronic toxicological 
studies.
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Preliminary invitro AChE inhibitory activity
The  Ellman  method  for  the  Acetyl  cholinesterase  assay  was 
standardized and validated.    
The  preliminary  observation  of  the  various  extracts  of  leaves  of 
P.granatum by invitro study showed significant AChE inhibitory activity in 
the following order in a dose dependent manner .
Chloroform extract > ethanol extract > acetone extract.  
The IC50 value for chloroform acetone, ethanol extracts were 1.8, 2.1, 
1.8mM respectively.  It is comparable with the standard drug tacrine.
It is concluded that it can be optimistic that the present investigation 
present a herbal drug of a safe and potential chemotherapeutic target in the 
treatment of Alzheimer’s disease and commercial exploitation of ursolic acid 
extraction.   AChE inhibitors,  which  enhance  cholinergic  transmission  by 
reducing the enzymatic degradation of acetylcholine, are the only source of 
compound  currently  approved  for  the  treatment  of  Alzheimer’s  Disease 
(AD)  by  U.S.  Food  and  Drug  Administration  (USFDA)  and  European 
medicines Agency (EMEA). 
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